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ABSTRACT
Peterson, Brent Michael. Effects of a Twelve-Week Aerobic and Cognitive Training
Intervention on Cognitive Function in Cancer Survivors. Published Doctor of
Philosophy, University of Northern Colorado, 2015.
Chemotherapy-related cognitive impairment (CRCI) has been reported to negatively
affect upwards of 75% of cancer patients. Decreased reaction times, cognitive and
linguistic inabilities, decreased quality of life (QOL), decreased concentration and
memory, and attentional difficulties may be due to CRCI. Exercise and cognitive
training, independently, have been shown to improve functional capacity and aspects of
cognitive function in various populations. However, to our knowledge there have been no
studies that have examined the effects of aerobic and cognitive training on cognitive
function in cancer survivors. Purpose: To examine the effects of a quasi-randomized,
controlled 12-week or 36 session aerobic and cognitive intervention on cancer survivors
(CAN) versus non-cancer participants (NC). Methods: CAN (n = 28) who were in
treatment or had completed treatment within eight weeks and NC (n = 7) were included
in this study. Pre and post physical and cognitive assessments, Beck Depression, QOL,
and Piper fatigue inventories were completed. Following initial assessments, a 12-week
computer-based cognitive training and flexibility training intervention was conducted.
CAN participants were assigned to aerobic, flexibility, and cognitive training (CANAER-COG), aerobic and flexibility training (CAN-AER), flexibility training only (CANCON), or cognitive and flexibility (CAN-COG) training groups. The apparently healthy
group completed aerobic, flexibility, and cognitive training (NC-CON). Results: No
iii

significant (p > 0.05) main effects were observed between groups for all variables of
interest. Wilcoxon sign ranks tests revealed significant improvements among withingroup measures. The AER-CAN-COG significantly (p < 0.05) decreased (-33%) in the
Piper B subcategory. The CAN-AER group significantly (p < 0.05) increased in measures
of logical memory raw and scaled scores (28%, 33%, respectively), delayed recall raw
and scaled scores (39%, 27%, respectively, p < 0.05), block design raw and scaled scores
(20%, 19%, respectively, p < 0.05), and letter-number sequencing scaled scores (12%, p
< 0.05). Piper S scores significantly (34%, p < 0.05) decreased while the Piper C subscale
trended toward significant (p = 0.06) decreases (26%). The CAN-CON group
significantly (p < 0.05) increased in gender, age, and education verbal fluidity scores
(750%, 320%, and 205%, respectively). VO2peak trended toward significant increased,
while QOL significantly increased (16%, p = 0.05; and 26%, p < 0.01, respectively). The
NC-CON group delayed recall scaled scores trended toward significant increases (12%, p
= 0.07). The CAN-COG group failed to significantly (p < 0.05) increase in any measure
of cognitive function. Beck depression significantly (p < 0.05) decreased (-59%) and
QOL significantly (p < 0.05) increased (6%). Conclusion: Aerobic training impacted
cognitive, physiological, and psychosocial measures the greatest. Individually, cognitive
training and flexibility training resulted in notable cognitive, physiological, and
psychosocial improvements. Yet, the combined cognitive, aerobic, and flexibility training
failed to produce the synergistic and compounded results as hypothesized. Results
suggest that, individually, aerobic, cognitive, and flexibility training are appropriate for
addressing CRCI in this population, but combined training of this nature may actually be
too demanding for those undergoing treatment.
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CHAPTER I
INTRODUCTION
Cancer patients experience a multitude of various physical, emotional, and
psychological effects during and following chemotherapy. Despite the substantial
methodological improvements, the positives are matched with sometimes debilitating
negative side effects. Of the many different side effects that may occur with treatment, 475% of patients have been estimated to experience some form of cognitive dysfunction
following treatment (Jackson, 2008; Konat, Kraszpulski, James, Zhang, & Abraham,
2008; Myers, 2009; Raffa & Tallarida, 2010). Staat and Segatore (2005) reported that
cognitive impairment associated with chemotherapy treatment has been often described
as “chemo-fog” or “chemo-brain;” however, it has more recently been defined as
chemotherapy-related cognitive impairment (CRCI) (Myers, 2009; Wefel, Lenzi,
Theriault, Davis, & Meyers, 2004). A formal definition of cognitive function is cognitive
action in the everyday world. It is multifaceted, being composed of attention, language,
learning and memory, visual-spatial processing, executive skills, and reasoning (La Rue,
2010). It (CRCI) has been described as presenting itself as impaired speed of processing
information or reaction time, cognitive inability, and diminished organizational skills, as
well as decreased linguistic abilities, and attention (Staat & Segatore, 2005). In addition,
executive function, described as foresight, hindsight, and judgment may also be
negatively impacted.
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Chemotherapy-related cognitive impairment has been reported to negatively
affect patients’ quality of life (QOL), impact daily living activities, impair memory and
concentration, and may persist long after completion of treatment (Carlsson, Strang, &
Bjurstrom, 2000; Mitchell & Turton, 2011; Schilling, Jenkins, Morris, Deutsh, &
Bloomfield, 2005). Patients have also described CRCI as forgetfulness,
absentmindedness, and an inability to focus while performing daily tasks (Hess & Insel,
2007).
Three potential mechanisms have been proposed to help illuminate the
mechanisms of CRCI. These are immunologic or inflammatory toxicity, direct
neurotoxicity, or micro-vascular toxicity (Saykin & Ahles, 2003). Proliferating cells are
targeted by chemotherapy, and these drugs (such as 5-fluorouracil) are able to cross the
blood-brain barrier, and collect in cerebral-spinal fluid (Bourke, West, Cheda, & Tower,
1973; Kerr, Zimm, Collins, O’Neill, & Poplack, 1984). Chemotherapy-related cognitive
impairment memory deficits may be due to direct toxicity on neurogenic zones such as
the denate gyrus of the hippocampus (Mustafa, Walker, Bennett, & Wigmore, 2008).
More recent evidence suggests that CRCI may be linked to cytotoxic agents releasing
excessive cytokines contributing to toxic collateral damage to healthy tissue, potentially
disrupting cognitive performance (Raffa, 2011).
In human and animal chemotherapeutic treatment models, investigators have
demonstrated decrements in short-term memory and high order brain function (Konat et
al., 2008), memory acquisition impairment (Liedke et al., 2009), learning and memory
impairment (Schilling, Jenkins, Morris, Deutsh, & Bloomfield, 2005; Winocur, Vardy,
Binns, Kerr, & Tannock, 2006), spatial memory, neutrotrophic protein, neurogenic
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protein, vascular proliferating cell dysfunction (Mustafa et al., 2008), contextual memory
dysfunction (Macleod et al., 2007), verbal and working memory impairment (Schilling,
Jenkins, Morris, Deutsh, & Bloomfield, 2005), decreases in cerebral white matter,
processing speed (Deprez et al., 2011), and decreases in attention/concentration scores
(Yoshikawa et al., 2005).
It has been well established that exercise has been positively associated with
increases in cardiopulmonary function, resting heart rate, pulmonary function, forced
vital capacity (FVC), upper-body muscular endurance, lower-body muscular endurance,
core muscular endurance and flexibility, as well as reductions in behavioral, sensory,
affective, cognitive and mood, total fatigue scores, and reductions in inflammation in
apparently healthy populations (Fairey et al., 2005; Hsieh et al., 2008; Schneider, Hsieh,
Sprod, Carter, & Hayward, 2007a; Schneider, Hsieh, Sprod, Carter, & Hayward, 2007b;
Schneider, Hsieh, Sprod, Carter, & Hayward, 2007c; Van Weert et al., 2010).
Furthermore, investigators have also demonstrated that aerobic exercise and cognitive
training may increase QOL and cognitive function in apparently healthy adults, cancer
survivors, and Alzheimer’s patients (Ferguson et al., 2007a; Potter, & Keeling, 2005;
Wood, Alvarez-Reyes, Maraj, Metoyer, & Welsh, 1999), increase cognitive control and
attention (Hillman et al., 2009), improve cognitive function and recall (Lautenschlager et
al., 2008), and increase mental speed, memory, reaction time, attention, and cognitive
flexibility (Masley, Roetzheim, & Gualtieri, 2009). In addition, during brain-based
cognitive training studies using Posit-Science®, a commercially available home brain
training software, investigators have demonstrated improvements on auditory processing
speed, self-reported everyday cognitive skills, memory performance, increases in speed
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and accuracy of central auditory system, and benefits potentially lasting well beyond the
training interventions (Mahncke, Bronstone, & Merzenich, 2006; Mahncke et al., 2006;
Smith, et al., 2009). However, to our knowledge, there were no current studies that had
examined a combined exercise and cognitive intervention on measures of cognitive
function in a cancer rehabilitation population.
Statement of Purpose
Therefore, the purpose of this study was to examine the effects of a quasirandomized, controlled 12-week aerobic and cognitive intervention on cancer survivors
(CAN) versus non-cancer participants (NC).
Research Hypotheses
H1

Aerobic training consisting of moderate intensity cycling on a stationary
cycle ergometer would increase measures of cognitive function in CAN.

H2

Cognitive training using computer software consisting of brain training
exercises would increase measures of cognitive function in CAN.

H3

The combined cognitive and aerobic training would have a synergistic
effect on increases in cognitive function in CAN.
Significance of Study

Cancer is a staggering disease. Global estimates have revealed that approximately
12.7 million people were diagnosed with cancer as of 2008 (Jemal, Bray, Center, Ferlay,
Ward, & Forman, 2011). The efforts to treat the disease are often times accompanied by
varying degrees and severity to which treatment-related side effects may occur. In the
war on cancer, the patient is often prescribed treatment modalities that may affect
physical, psychological as well as cognitive abilities of the individual. The phenomenon
of cognitive dysfunction related to chemotherapeutic treatment, commonly known as
“chemo brain” or “chemo fog” may present considerably different among individuals.

5
Regardless, there is substantial information to suggest that certain areas of the brain are
affected by current methods of treatment for cancer. The mission of cancer rehabilitation
at The Rocky Mountain Cancer Rehabilitation Institute (RMCRI) is to relieve suffering,
promote self-sufficiency, improve quality of life, and eliminate secondary cancers and
cancer recurrence for cancer survivors through prescriptive exercise and nutrition
evidence-based interventions. By implementing methods of aerobic exercise, flexibility,
and cognitive training using a specifically designed software program to target areas of
the brain most affected by treatment, not only will the mission be upheld, but this
approach to cancer rehabilitation is completely novel. To our knowledge there were no
other quasi-randomized or controlled studies conducted using specific cognitive training
interventions combined with elements of exercise on cancer survivors in a cancer
rehabilitation program.
Limitations
Although the novelty of this project was the major strong point of this study,
much akin to many studies throughout history, many unforeseen limitations presented
themselves throughout the course of data collection. The limitation with the most
noteworthy influence on the process of data collection was the complexity of cancer
itself. When clients are referred to the RMCRI, they may present at very different time
points along the cancer continuum. We had participants who initially qualified for the
study but presented at different stages, types of cancer, types of treatment, combinations
of types of treatment and stages, and experienced a multitude of physiological and
psychological responses to the treatment itself. Despite working with cancer survivors
since 2008, having immersed myself in the literature, and having a modicum of
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expectations, most participants presented with a combination of factors that forced
reevaluation on an individual and frequent basis. For example, a particular participant
(who was prescreened and met qualification standards for this study) was undergoing
treatment for stage III brain cancer and would often have moments where she would
randomly cease talking, slow or stop cycling, and appear to be awake, but not coherent. It
was determined that because of her type of cancer, treatment, and being on frequently
oscillating dosages of GABApentin that this was something that needed to be addressed
on a daily basis, but did not fit the requirements for removal from the study. Throughout
the study she continued to improve, but because of her particularities, we had to make
appropriate adjustments in order to accommodate her needs. In addition, treatmentrelated side effects were also a source of difficulty. Since many were undergoing
treatment, dosages and regimens often changed, and because many times participants,
especially those who were undergoing treatment, often did not feel well enough to
complete physical or cognitive training to the exact specifications of the study. When the
study began in 2010, the process of referral from local oncologists predominantly
included those that had just completed treatment or were upwards of eight weeks out of
treatment. As the study progressed, the amount of referrals of clients that were currently
undergoing treatment continued to increase to a point where those who were out of
treatment were seldom observed. In light of the individual experiences with treatment,
often times training had to be reduced to a comparable rate of perceived exertion (RPE)
just so ambitious clients who were so worn out from treatment in the preceding days
could complete the training without harming themselves. Medical emergencies,
recurrence, inclement weather, holidays, or last minute appointment changes with
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physicians were also significant factors in the delay of completing this study. For
example, a particular client that, again was prescreened and qualified for the study, had a
medical emergency where he contracted an infection near an incision site and
consequently was admitted to the hospital for a month. Even though the requirements
were explicitly conveyed prior to the start of the study, it is almost impossible with this
population to expect perfect adherence. For example, all participants in the study had
work or family-related situations which inhibited them from making all training sessions.
In addition, participants included during the fall semesters were often the most difficult to
complete because of the amount of family holidays that occur from late October until
after January. Furthermore, clients dropping the study for health-reasons was also a factor
that inhibited the completion of this study within the confines of the proposed timeline.
Small sample sizes were a substantial limitation in this study for both the CAN and NC
groups. Had the proposed amount of subjects refrained from withdrawal from this study,
group differences may have been more pronounced. Yet, many participants did withdraw,
which forced the alterations in statistical analyses. In fact, for the N of 35 that was
completed and considered for this analysis, a total of 11 participants dropped the study at
some point between 2010 and 2014. Furthermore, not all participants completed every
single assessment variable of interest in this study. Consequently, data imputation
methods were employed to explain approximately 1.3% of cognitive data and 3.6% of
physiological and psychosocial data. This is reported in greater detail in the methods
section. Finally, with the many other factors that acted as barriers to the completion of
this study, death of participants because of cancer was also a factor that, sorrowfully,
occurred for a couple of people directly following their involvement in the study. One
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participant in particular passed away from brain cancer during the course of the study.
Taken together, the results of this study should be interpreted with caution.
Assumptions
This study was based on the assumptions that participants would follow the
instructions for maintaining normal activities of daily living (ADL) and not be involved
with any other forms of physical exercise beyond what was administered during the
study. With respect to the condition of each individual as cancer survivors, all
participants were screened via a preliminary phone conversation for health-related
conditions that would have been considered detrimental to the outcomes of the study and
therefore were considered in relatively good health pending completion of a physical
assessment. Participants were also prescreened for cognitive impairments and tested for
sound mental status via Mini Mental Status Examination (MMSE) and were, therefore,
considered mentally capable to participate in this study.
Definition of Terms
Cancer: A group of diseases characterized by uncontrolled growth and spread of
abnormal cells (American Cancer Society, 2014).
Executive Control/Function: A subset of multiple procedures including: planning,
working memory, scheduling, task coordination, and interference control
(Hillman et al., 2006).

Non Matching to Sample testing: A series of paired sample and test trials focused on
object recognition and non-spatial memory testing. The stimulus for the testing
consists of a series of suspended cylinders above a water maze where rodents
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must recognize familiar objects when placed in novel areas while being timed
(Winocur et al., 2006).
Cognitive Function: Cognitive action in the everyday world. It is multifaceted, being
composed of attention, language, learning and memory, visual-spatial processing,
executive skills, and reasoning (La Rue, 2010).
Anisotropy: Diffusion that is dependent on direction (Beaulieu, 2002).
Morris Water Maze Test: Test of reference memory depending on functional integrity of
rodent hippocampal tissue (Morris, Garrud, Rawlins & O’Keefe, 1982).
Brain derived neurotropic factor (BDNF): Reported to be involved in neurogenesis
cultivation, learning, and memory (Mustafa et al., 2008).
Dentate Gyrus: Region of brain located within the hippocampus reported to be associated
with neuronal proliferation and neurogenesis (Mustafa et al., 2008).
Ovariectomized: Surgical removal of one or both ovaries (Macleod et al., 2007)
Hippocampus: Limbic system component with the amygdala. The location of the
hippocampus is composed of the medial aspect of the temporal lobe. Bilateral
brain damage may inhibit new memory acquisition and retention; however, pre
tissue insult memories may remain. Limbic structures have been reported to aid in
the consolidation of memories but not storage (Marieb and Mallatt, 1997).
Praxis: The ability to carry out learned or purposeful action.

List of Abbreviations
WMS IV BCOG: Weschler Memory Scale (4th Ed.) general cognitive screener.
WMS IV LMI Raw: Weschler Memory Scale (4th Ed.) Logical Memory I raw score.
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WMS IV LMI Scaled: Weschler Memory Scale (4th Ed.) Logical Memory I scaled score.
WMS IV LMII DR Raw: Weschler Memory Scale (4th Ed.) Logical Memory II delayed
recall raw score.
WMS IV LMII DR Scaled: Weschler Memory Scale (4th Ed.) Logical Memory II delayed
recall scaled score.
WMS IV LMIICP Raw: Weschler Memory Scale (4th Ed.) Logical Memory II cumulative
percentage raw score.
TMT A Raw: Trail Making Test A raw score.
TMT B Raw: Trail Making Test B raw score.
WAIS IV BD Raw: Weschler Adult Intelligence Scale (4th Ed.) Block Design raw score.
WAIS IV BD Scaled: Weschler Adult Intelligence Scale (4th Ed.) Block Design scaled
score.
WAIS IV LNS Raw: Weschler Adult Intelligence Scale (4th Ed.) Letter Number Sequence
raw score.
WAIS IV LNS Scaled: Weschler Adult Intelligence Scale (4th Ed.) Letter Number
Sequence scaled score.
WAIS IV CD Raw: Weschler Adult Intelligence Scale (4th Ed.) Coding raw score.
WAIS IV CD Scaled: Weschler Adult Intelligence Scale (4th Ed.) Coding scaled score.
COWAT Z G: Controlled Oral Word Association Test gender z-score.
COWAT Z A: Controlled Oral Word Association Test age z-score.
COWAT Z ED: Controlled Oral Word Association Test education z-score.
SBP: Systolic blood pressure.
DBP: Diastolic bold pressure.
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RHR: Resting blood pressure.
VO2peak: The highest rate of oxygen consumption measured during the exercise test,
regardless of whether a VO2 plateau is reached.
SANDR: Sit and Reach test.
PIPER I: Piper Fatigue Index overall score.
PIPER B: Piper Fatigue Index behavioral score.
PIPER A: Piper Fatigue Index affective score.
PIPER S: Piper Fatigue Index sensory score.
PIPER C: Piper Fatigue Index cognitive/mood score.
BECK: Beck Depression Inventory score.
QOL: Quality of Life score.
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CHAPTER II
REVIEW OF LITERATURE
Cancer Overview
On a global scale, cancer is a substantial health concern. From a fiscal standpoint,
by 2020 it is projected that direct annual costs of cancer will skyrocket from
approximately $104 billion in 2006 to over $173 billion (Smith & Hillner, 2011). From
an overall healthcare standpoint, cancer has been described as being multifaceted, having
multiple, considerable factors to be aware of when approaching the topic. The American
Cancer Society (ACS), in Cancer Facts & Figures 2014, described the postulated causes
of cancer as being composed of potentially several internal and external factors. The
internal factors may be composed of one or a combination of inherited and/or metabolic
mutations, and compromised hormonal and/or immune function. External factors may
include exposure to: chemicals, radiation, infectious organisms, and/or tobacco products.
It is estimated that a total of 1,665,540 new cases of cancer were expected to be
diagnosed in the United States in 2014 (ACS, 2014). The probability, in one’s lifetime, of
being diagnosed with some form of invasive cancer is 44% and 38% for males and
females, respectively (Siegal, Naishadham, & Jemal, 2013). In addition, 585,720 people
are also projected to succumb to the disease, with as many as 1600 people expected to
perish each day.
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Approximately one third (195,240) of the 585,720 deaths will be related to obesity, poor
nutrition, and inactive lifestyles, which could be considered preventable occurrences.
Behind heart disease, cancer is the second leading cause of death (ACS, 2014; Siegal et
al., 2013). As disparaging as those numbers sound, Kohler et al. (2011) indicated that in
data collected from 1975-2007, overall cancer incidence and mortality rates have
decreased 1% across all races. More recent data (2005-2009) have indicated that
incidence numbers across all races have maintained at 1% however, death rates have
decreased 1.8% per year in men, and 1.5% per year in women, with the noted exception
of Native Americans and Alaska Natives. These reductions have been attributable to,
what was described as, “avoidances” of 1,180,000 deaths from cancer in the United
States, since 1990 (Siegal et al., 2013). The five-year relative survival rate for all cancers
diagnosed between 2002 and 2009 is 68%, up from 49% from 1975-1977 (ACS, 2014).
In addition, our laboratory also found specifically individualized cancer rehabilitation
interventions to be associated with significant increases in five-year survival rates
(Peterson, Repka, Hayward, & Schneider, 2010). These witnessed reductions in death and
increased five-year survival rates may be attributable to current progressive methods of
prevention, detection, education, improved precision of treatment methods, as well as
increased implementation of individualized cancer rehabilitation programs.
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Effects of Chemotherapy on the Brain
In recent years, chemotherapeutic interventions have been instrumental in
contributing to the survival and clinical outcomes of cancer patients. The positive effects
that are witnessed with chemotherapy and associated cancer treatments are often matched
or exceeded by the many different types of negative side effects. During the past two
decades, notoriety has advanced within the body of literature regarding attention and
memory decrements associated with chemotherapy treatment (Ferguson, Cassel, &
Dawson, 2010). Approximately 77% of all cancer(s) diagnosed generally occur among
those who are 55 years of age or older (ACS, 2014). With the combination of advances in
detection and treatment methods, it is likely that more people will be either living with
cancer, have been diagnosed and are residing within the treatment spectrum, or are
beyond the process. Matsuda et al. (2005) reported that at least 10-40% of breast cancer
survivors may experience various gradations of cognitive deficits when returning to their
daily lives, negatively affecting QOL. With regards to cognitive difficulties witnessed
during and following various chemotherapeutic treatments, there is an increasing demand
to address this matter of survivorship and develop methods to better approach the issue,
whether that be symptom management or rehabilitation to reduce, or offset some of the
witnessed side effects, has yet to be determined.
Cognitive dysfunction or impairment that is associated with chemotherapy
treatment has been reported in the literature as far back as the early 1980’s. During
various neuropsychological assessments, chemotherapy treatment has been indicated to
negatively affect anxiety, stress, and depressive symptoms. Each having been observed in
various extents in cancer patients, and have been suggested to adversely influence these
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cognitive testing measures (Ferguson et al., 2010). In addition, during the early 1990’s a
substantial portion of the literature was focused on elements of sustained attention and
working memory and how they are affected by various chemotherapeutic agents. Of the
more prominent investigations on the topic, Van Dam et al. (1998) examined levels of
cognition in high-risk breast cancer patients receiving standard or high dosages of
chemotherapy. Thirty-two percent of the high dosage group and 17% of the standard
dosage group exhibited significantly noticeable measures of cognitive dysfunction, as
compared to 9% witnessed in the control group; this indicates a greater risk of cognitive
impairment with increasing dosages of chemotherapy. However, the observed
psychological and cognitive dysfunction by the investigators was attributed to emotional
distress as opposed to direct or indirect effects of chemotherapy (Van Dam et al., 1998).
In retrospect, Ferguson et al. (2010) elucidated that the compilation of CRCI literature
during the 1990’s could be considered an establishment of the functional relationship
between chemotherapy dosage and observed cognitive dysfunction. When chemotherapy
dosage increased, so did the level to which cognitive dysfunction was observed or
experienced.
Chemotherapy and the intended toxicities on cancer cells, unfortunately have
inadvertent effects on healthy cells (Raffa, 2011). In addition, these observed toxicities
have been speculated to elicit extensive collateral damage to healthy tissue, as well as
components of the central and peripheral nervous systems. Of those who have
experienced chemotherapy-related side effects, an estimated 4-75% of patients
experience some form of cognitive dysfunction following treatment (Jackson, 2008;
Konat et al., 2008; Myers, 2009; Raffa & Tallarida, 2010). Therefore, understanding
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CRCI is an important aspect to cancer rehabilitation. More recent evidence may suggest
that these cognitive dysfunctions may be related to excessive cytokine release by
cytotoxic agents, inflammatory issues, or direct neurotoxicity.
Cognitive Functioning
La Rue (2010) formally defined general cognitive functioning as daily cognition
in action. Furthermore, language, executive functioning, learning, memory, visuo-spatial
processing, and attention have been described as components of cognitive functioning. It
is possible for individuals to classify as “fit” in certain areas like language and attention
but may be less fit in other areas like learning or executive functioning (La Rue, 2010).
Individuals with optimal brain fitness levels should be absent of brain disease or systemic
illness that may critically disrupt normal brain function. Although, La Rue (2010)
suggested that brain fitness may be impacted by genetic predispositions, endowments,
lifestyle choices, and life experiences thereby making the task of monitoring brain fitness
difficult to quantify.
In elderly breast cancer patients, Wefel, Saleeba, Buzdar, and Meyers (2010)
examined the effects of pre-existing cognitive impairments prior to administration of
treatment. The investigators measured affective status, QOL, and cognitive function
before and after treatment. Wefel et al. (2010) determined that although 21% of patients
were cognitively impaired prior to treatment, 65% of the sample exhibited significant
declines in measures of learning, memory, executive function, and processing speed in
analyses following treatment. Sixty-one percent experienced cognitive decline, with 30%
displaying onset of previously unobserved cognitive impairments (Wefel et al., 2010).
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Therefore, it may be worthwhile to consider that there may be a compounding effect of
CRCI and pre-existing cognitive dysfunction witnessed in elderly cancer patients.
As of 2005, 925 million people across the globe were estimated to be 55 years of
age or older. By 2015 this cohort is expected to increase to 1.4 billion people (Angevaren,
Aufdemkampe, Verhaar, Aleman, & Vanhees, 2008). Research has indicated that agerelated cognitive declines involving processing and working speed, and short and longterm memory are related to changes in brain structure and function (Hillman et al., 2006).
In older adults, who have not had cancer, it is estimated that 3-19% will have experienced
various elements of mild cognitive impairment which may be characterized by impaired
performance on memory tasks and memory complaints (Belleville et al., 2006).
Pre-dispositional engagement has been defined as the relatively stable mental disposition
toward the enjoyment of a novel task, intellectual challenge, and creativity (Parisi, StineMorrow, Noh, & Morrow, 2009). In the investigation of relationships between the
approaching of experiences in a mindful and creative way, cognition, and activity of
participation in older adults, Parisi et al. (2009) administered a battery of neuropsychological tests that evaluated processing speed, working memory, inductive
reasoning, visuo-spatial processing, activity level, divergent thinking, and mental
engagement predisposition. Factor analyses were then run on data collected from the
neuropsychological tests to evaluate dimensions of engagement in various activities.
These dimensions were also compared to overall cognition. The investigators found that
performance on cognitive assessments could be explained, in part, by level of enjoyment
and preference toward intellectually stimulating challenges. In particular, older adults
who engaged in intellectually challenging activity tended to approach life experiences
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with greater levels of creativity, thoughtfulness, and curiosity than their counterparts.
Additionally, these older adults appeared to maintain healthy levels of lifetime cognitive
functioning, which was a positive factor for cognitive vitality throughout life. Belleville
et al. (2006) assessed a two-month cognitive training intervention with older adults
experiencing mild cognitive impairment against older adults with normal levels of
cognitive aging. The training included addressing episodic memory performance through
mnemonics and semantic elaboration. The investigators found that the aforementioned
cognitive training produced positive and long-lasting effects in healthy older adults’
cognitive performance.
Age-associated cognitive losses may be substantially ameliorated by physical
activity. Hillman et al. (2006) assessed primarily the executive control component of
cognition function related to physical activity in 241 participants ranging from 15-71
years of age. The investigators evaluated physical activity by self-reported number of
walked city blocks and estimated caloric expenditure. Executive control was defined as
being a subset of multiple procedures including: planning, working memory, scheduling,
task coordination, and interference control. These processes were reported to have an
involvement in the intentional component of interaction with the environment, which
may also decline with age. However, physical activity may serve to protect against losses,
with the greatest benefits witnessed in some aspect of executive control. The results
indicated that response accuracy (% correct) increased as amount of physical activity
(days per week) increased across all conditions for older adults [(congruent condition) 0,
88%; 1, 92%, 2, 93%, 3, 95%, and 4, 97%, p < 0.05], [(incongruent condition) 0, 65%, 1,
81%, 2, 82%, 3, 86%, and 4, 88%, p < 0.05]. For the older adults, greater levels of
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physical activity were associated with performance on tasks eliciting greater accuracy of
responses. There were no significant (p >0.05) associations between physical activity and
accuracy of responses for the younger adults [(congruent condition) 0, 97%, 1, 95%, 2,
97%, 3, 97%, and 4, 96%], [(incongruent condition) 0, 88%, 1, 90%, 2, 86%, 3, 91%, and
4, 85%]. No differences were observed between the groups for task conditions containing
smaller executive control components, suggesting that aerobic fitness may selectively
protect against cognitive aging on tasks requiring extensive executive control. The
investigators concluded that physical activity may be beneficial to cognition during early
and middle periods of the human life span and may continue to protect against agerelated loss of cognitive abilities during older adulthood (Hillman et al., 2006).
In a review of literature, Angevaren et al. (2008) examined studies that
incorporated fitness, cognitive functioning, and physical activity in sample populations
reporting ages of participants greater than 55 years. The analysis of literature revealed
significantly positive effects of exercise on cognitive speed, delayed memory functions,
and visual attention as compared interventions other than listed [(SMD random effectscognitive speed) 0.3, 95% CI (0.04, 0.5), p < 0.05, (SMD random effects-visual attention)
0.3, 95% CI (0.02, 0.5), p < 0.05). In studies that compared aerobic training interventions
to balance or flexibility programs, the positive effects of aerobic exercise were
significantly greater in delayed memory functions, than balance or flexibility alone. As
compared to no intervention (controls) the effects of aerobic exercise on cognitive
function yielded significant positive effects on auditory attention [(WMD random effects)
0.5, 95% CI (0.1, 0.9), p < 0.01) and motor function (WMD random effects 1.2, 95% CI
(0.2, 2.2), p < 0.05). In a majority of the studies, improved VO2max values of

20
approximately 14% were also linked to improvements in cognitive function; specifically,
improvements in cognitive speed, delayed memory recall, observed motor function, and
auditory and visual attention capabilities.
Mechanisms of Cognitive Dysfunction
In a review of literature, Ahles and Saykin (2007) stated that risk factors for the
development of cancer and CRCI have been suggested as being composed of shared
genetic risk factors which may include low efficiency efflux pumps, dysfunctional DNA
repair mechanisms, and immune response incapacitation. The combined systemic effects
of chemotherapy and the aforementioned shared genetic risk factors may pose as
negatively compounding contributors to cognitive decline in patients following
chemotherapy. Changes in cognitive abilities may present subtly and may occur at a
range of gradations across various domains of cognition. Ahles and Saykin (2007)
elaborated on the primary model of classical thought regarding cognitive dysfunction
following chemotherapy. Treatment itself was suspected to be a secondary or tertiary
factor originating from psychological complexities such as anxiety, fatigue, or
depression. In studies implementing brain imaging techniques, the investigators indicated
volumetric alterations in brain tissue have been associated with chemotherapy dosage. In
addition, the investigators described that some studies have even shown that white matter
integrity and volumes of brain constituencies profoundly involved in cognitive function
have been observed to reduce in patients who have undergone chemotherapy. Ahles and
Saykin (2007) also noted that within the realm of normal central nervous system function,
cytokines play a substantial role in the modulation of glial and neuronal functioning,
metabolism of dopamine and serotonin, and neural repair. The neurotransmitters
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serotonin and dopamine play an important role in normal cognitive functioning, and have
been associated with neurotoxicity and neurodegenerative disorders such as Parkinson’s
disease, Multiple Sclerosis, and Alzheimer’s disease. Furthermore, cytokine induced
“sickness behavior” is also associated with cognitive disturbance, fatigue and depression
separate from cancer occurrence (Ahles & Saykin, 2007).
More recent literature has expanded on the concept that certain cytokines,
specifically IL-1β, IL-6, and TNF-α play a significant role in complex cognitive
processes, such as synaptic plasticity, neuro-genesis, and neuro-modulation. McAfoose
and Baune (2009) indicated that cytokine-mediated cognitive processes may substantially
facilitate the pathogenesis and long term development of specific neuropsychiatric
disorders such as depression and dementia. Identification of this central role in various
brain activities illuminates the mechanisms of brain function and elaborates on biological
mechanisms, especially synaptic plasticity, memory, and cognition. McAfoose and
Baune, (2009) referred to cognition as the combination of collective processes, such as
attention, learning, executive function, memory, language, and consciousness. Of these
cognitive processes, much of the research has centered on memory and learning.
Depression may also represent an exaggerated form of cytokine-mediated behavior even
in apparently healthy individuals. Individuals exhibiting “sickness behavior” are likely
generating a hyper-expressed state of bioavailable cytokines similarly akin to disease
models. In apparently healthy individuals, the investigators noted, these physiological
modifications are adaptive and may be triggered by psychological stress.

22
Brain Structural Alterations
Phenotypic relationships between intelligence and brain volumes have been
examined in many different studies. Wallace et al. (2010) examined the shared genetic
and environmental factors between brain volumes and intelligence in a population sample
composed of 649 adolescents, children, twins, and singletons. There were observed
relationships between brain volumes and intelligence, however they were insignificant.
Volumes of gray matter were uniquely affected by measured verbal perspicacity, whereas
non-verbal skills were reported to have an association with gray and white matter brain
regions. This would suggest that there are distinct mechanisms that may contribute to the
relationships between brain volumes and verbal/non-verbal intelligence. There were no
significant differences in brain volume means or variances between monozygotic (MZ)
twins, dizygotic (DZ) twins, singletons, and siblings of twins (1172.5 ± 106.5cc, 1146.1 ±
105.9cc, 1164 ± 117.5cc, and 1165.8 ± 118.6cc, respectively), with the exception of
significant volume differences in lateral ventricles among MZ and siblings of twins (11.5
± 6.6cc, and 8.4 ± 4.1cc) ventricles. A majority of correlations (phenotypic) were
significant (gray matter + white matter p < 0.01, r = 0.1; gray matter p < 0.01, r = 0.1;
white matter p < 0.05, r = 0.1; frontal gray matter p < 0.01, r = 0.1; frontal white matter p
< 0.01, r = 0.1; parietal gray matter p < 0.01, r = 0.1; temporal gray matter p < 0.01, r =
0.1; temporal white matter p < 0.01, r = 0.1; and the caudate nucleus p < 0.01, r = 0.2);
however, they were small. A significant genetic correlation was also detected between the
caudate nucleus volumes and vocabulary scores; however, after statistical correction,
only unique environmental correlations for frontal gray matter, gray matter + white
matter, and total gray matter remained significant (frontal gray matter p < 0.01, r = 0.1;
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gray matter p < 0.01, r = 0.13; and total gray matter p < 0.05, r = 0.1). The findings
suggest that different genetic and environmental influences may underpin the phenotypic
relationship between brain volumes and verbal versus visual-spatial skills; however,
Wallace et al. (2010) were unable to directly or succinctly model those shared
contributions.
In a case study examining cognitive function between one set of twins (one who
had received chemotherapy and one who did not), Ferguson, McDonald, Saykin, and
Ahles (2007b) examined how chemotherapy would elicit cognitive changes between
siblings. The twin that underwent chemotherapy received four cycles of doxorubicin
(DOX), cyclophosphamide, tamoxifen, and docetaxel. There were significantly greater
amounts of verbal complaints of cognitive trouble reported for the twin who had
undergone chemotherapy as compared to the untreated twin. The investigators reported
that during structural image testing that there were no significant volumetric differences
witnessed. However, the investigators also noted that the treated twin’s cortical activity
pattern was increased significantly greater than that of the untreated twin. Volumes of
white matter lesions were observed to be greater in the treated twin in the left (6075 mm3
vs. 3343.4 mm3, respectively, and right cerebral hemispheres (3725.7 mm3 vs. 2897.8
mm3, respectively). The investigators noted that these observed increases in activation of
cortical regions (as observed in functional magnetic resonance imaging) in the treated
twin’s brain may signify a compensatory adaptation of neural circuitry in unaffected
regions of the brain to the toxic effects of chemotherapy on affected regions.
Examination of brain activity has yielded results for cancer survivors as far out as
ten years. Silverman et al. (2007) administered positron emission tomography (PET)
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testing on age-matched apparently healthy older adults and breast cancer patients who
previously had undergone chemotherapy between five and ten years prior to examination.
Regardless of the time since treatment, those who had undergone chemotherapy
significantly differed from those who had not in neural activation patterns during shortterm memory tasks. In particular, those who had undergone treatment exhibited a
statistically significant, 2% increase in peak activation in the inferior frontal gyrus during
recall tasks. Performance on delayed recall tasks by chemotherapy-treated patients also
elicited 3.2 points less, or a 13% decrease when as compared to controls (20.6 ± 4.8 vs.
23.8 ± 6.3, respectively).The researchers noted that the areas that were significantly
active were the inferior frontal gyrus, the contralateral posterior cerebellum near the
midline, as well as the superior frontal gyrus. However, the most significant alterations in
brain activity were witnessed in the basal ganglia. Metabolism was significantly
decreased in patients who had received chemotherapy. The most substantial side-effects
patients reported having difficulties with were diminished attention, memory,
concentration, and processing speed disruption. The investigators also indicated that
cognitive-related complaints have typically centered on their perception of mental
slowness and diminished abilities to maintain attention, concentrate, and remember
things. Abnormal activation in the inferior frontal cortex during performances of shortterm memory tasks were witnessed in images taken from chemotherapy treated patients.
Untreated patients, in contrast, demonstrated greatest cortical activation in the parietal
and occipital cortices when performing the same task. Thus, overall, the altered cortical
activation associated with performance of a memory task in chemotherapy treated
patients could be characterized as involving greater recruitment of frontal cortical tissue.

25
Metabolism in the inferior frontal gyrus was significantly related to cognitive
performance on short-term memory recall tasks, suggesting that the chemotherapy
associated changes in cerebellar activation were related to cognitive deficits. The
observed increases in frontal activation may represent a compensatory response to lower
resting metabolism found in this region of the brain in chemotherapy treated, cognitively
impaired patients.
Brain Imaging and Direct Entry
of Chemotherapy
As previously stated, chemotherapeutic agents were classically thought to be
unable to cross the blood-brain barrier. However, in various human and animal models,
research has indicated that chemotherapeutic drugs have been observed in cerebrospinal
fluid and brain tissue. Drugs, such as 5-flourouracil, have been observed to traverse by
simple diffusion (Bourke et al., 1973; Kerr et al., 1984). Beaulieu (2002) described a
method that may help explain the mechanisms involved in chemotherapy traveling across
the blood brain barrier or traversing into other central nervous system structures. Direct
neurotoxicity may disrupt brain parenchyma, producing demyelination and/or altered
water content, resulting in white matter disruptions. Although this technical review
outlined anisotropic mobility of water, the investigators noted literature that examined the
effects of the methyl mercury and studies of vinblastine on nervous system components
during in vitro and in vivo animal models. The investigators indicated that in each of the
aforementioned models that anisotropy is a noticeable factor in the fluid mechanics of
neurological microstructure. The investigators also noted that with simple diffusion there
is a dependence on the interactions of the diffusing molecule which results in diffusion in
all directions. In anisotropic diffusion, there is a directional movement based on
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neurological structuring, much like the example of placing a cut portion of a flower or a
stalk of celery in a colored aqueous solution. There is a distinct method of diffusion of
color throughout the plant microtubules. Chemotherapeutic entry into central nervous
system components may follow this same delivery method.
Micro-structural abnormalities have also been observed in chemotherapy-exposed
brain white matter. Deprez et al. (2011) examined the cerebral white matter integrity of
patients, who had undergone chemotherapy. The investigators used magnetic diffusion
tensor imaging (DTI) as well as implemented measures of cognitive abilities. Decreased
performance on attention and processing speed analyses were significantly correlated
[(Attention) Bourdon-Wiersma Dot Cancellation Test-parietal p < 0.01, T = -5.5; Test of
Everyday Attention-auditory elevator-parietal p < 0.05, T = 6.1; (Processing Speed)
Nine-Hole Pegboard Test- parietal-temporal (3 measures) p < 0.01, p < 0.05, p < 0.05, T
= -5.5,-4.2, and -4.6; WAIS-digit symbol temporal p < 0.05, T = 5.7, and Trail Marking
Test-A- parietal p < 0.01, T = -5.3] with parietal and temporal white matter tracts,
suggesting micro-structural damage to white matter may underlie CRCI. The results of
this study indicated that there were significant differences witnessed in patients’ brain
volumes [(fractal anisotropy) .39 x 10mm2·s-1 vs. .43 x 10mm2•s-1 (mean diffusivity), .8 x
10mm2•s-1 vs. .7 x 10mm2•s-1, and (radial diffusivity) .6 x 10mm2•s-1 vs. .5 x 10mm2•s-1,
that underwent chemotherapy within four months of starting data collection. The
investigators concluded that the CRCI observed during cognitive assessments may be
attributed to recent chemotherapy treatment exposure.
High resolution magnetic resonance imaging (Hi-res MRI) and cognitive function
techniques conducted on breast cancer survivors and non-cancer patients have also been
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utilized to examine soft tissue damage in brain tissue at one and three-year intervals posttreatment (Inagaki et al., 2007). No significant differences in soft tissue damage were
observed between cancer survivors and apparently healthy non-cancer controls at one and
three-year increments. Although, smaller right prefrontal and parahippocampal regions in
the brain were reported for cancer patients whose time out of treatment was less than four
months. The investigators noted that significantly smaller frontal regions of the brain may
account for the decreases in score on attention/concentration and visual memory indices
of the WMS-R cognitive assessments. The prefrontal cortex, including superior and
middle frontal gyrus, has been reported to have roles in various functions including
memory, planning, execution, monitoring and cognitive processing, behavior, inhibition,
and change in circumstantial behavior. The investigators concluded that the current study
showed significantly smaller regional brain volumes (right middle frontal gyrus p < 0.05,
right superior frontal gyrus p < 0.05, right parahippocampal gyrus p < 0.05, left
precuneus p < 0.05, left parahippocampal gyrus p < 0.05, right cingulate gyrus p < 0.05,
and left middle frontal gyrus p < 0.05) in areas related to cognitive functions in cancer
survivors who received adjuvant chemotherapy. However, at the three-year assessment
there were no significant volumetric differences.
As speculated, the hippocampus plays a significant role in memory acuity, which
may be profoundly affected by the decreases in brain volumes observed during
chemotherapy. Yoshikawa et al. (2005) examined the effects of adjuvant chemotherapy
on hippocampal volumes in Japanese breast cancer survivors via magnetic resonance
imaging (MRI), and memory via WMS-R testing. Breast cancer patients included in the
study had completed chemotherapy regimens which included: cyclophosphamide,
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methotrexate, fluoruracil, DOX, tegafuracil, doxofluridine, and carmofur. There were no
significant differences witnessed in memory function, including the delayed recall index
and percent retention, or hippocampal volume observed between the treatment and nonchemotherapy group. There were, however, significant differences in the
attention/concentration scores (95.7 ± 9.5 vs. 100.7 ± 9.9) for those in the chemotherapy
group compared to those who did not receive chemotherapy. Some of the participants had
been out of treatment for three years when data were being collected for this study. The
investigators suggested that this may account for the lack of significance found between
groups, and may be attributable to healing and repair of damaged areas in the brain
following treatment.
In a review of literature, Myers (2009) stated that there are also a variety of
potentially associated factors that have been identified as contributors to CRCI. These
include: age, educational level, intelligence, social support, anxiety, depression, fatigue,
disease site, stage, and co-morbidities; treatment regimen, timing, duration, and
concomitant therapies; and hormonal levels, cytokine levels, damage to neural progenitor
cells, and the presence of apolipoprotein E-4 allele. Patients have described the effects of
cognitive dysfunction as forgetfulness, absentmindedness, and an inability to focus when
performing daily tasks (Hess & Insel, 2007).
Chemotherapeutic Agents
In a combined in vivo and ex vivo animal model, Han et al. (2008) found that
progenitor cells and oligodendrocytes were particularly vulnerable to clinically relevant
dosages of 5-FU. A major cause of decreased cell numbers in 5-FU treated cultures was
due to a reduction in progenitor cell division. When mice were treated in vivo with 5-FU,
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significant induction of apoptosis in multiple CNS regions were noted. In the corpus
callosum, there was also a significant increase in apoptosis at day one to approximately
70% above control values. However, six months following treatment, excessive apoptosis
was reported to have normalized following treatment. Mice that were treated with
chemotherapy were significantly deficient in delayed white matter. Midline longitudinal
sections of corpus callosum displayed scattered foci of demyelinated axons, including
partial or complete loss of the myelin sheaths and increases in interlaminar splitting of the
myelin sheaths. In examination of transverse sections, there were significant amounts of
degenerating axons with multi-laminated structures and collapsed centers, swelling of
axons and altered axonal cytoskeleton and organelles. The usage of 5-FU in the treatment
of many types of cancers is of concern considering the evidence of acute and delayed
toxicity side effects. The investigators also noted that even transient exposure to 5-FU
increased apoptosis by 2.5-fold in the subventricular zone and a 4-fold increase in the
dentate gyrus in the hippocampus. The investigators also noted that the increasing
amount of cells dying continued for 14 days, however was at normal values six months
following administration of 5-FU.
Van Der Kooy, Zito, and Roberts (1985) examined the effects of DOX
administration on brain tissue in Sprague-Dawley rats. The researchers separated the two
halves of the brain by strategic incisions and administered DOX unilaterally. The
protective effect of incisions against neurotoxicity was evidence to support the retrograde
transport of DOX which led to neurotoxic effects in the treated portion of the brain.
Administration of DOX was reported to have destroyed dopaminergic and thalamic
neurons, which are afferent to the striatum, and damaged gamma-aminobuteric acid
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(GABA) neurological interfaces via retrograde transport. The investigators concluded
that DOX may have useful purposes for discriminatory destruction of afferent neurons
localized to site of injection by way of retrograde transport.
Joshi et al. (2005) examined the effects of oxidative stress parameters in light of
the knowledge that Adriamycin (ADR) has been shown to produce reactive oxygen
species (ROS) upon administration. In addition, oxidative stress that is facilitated by free
radicals has been associated with neurodegenerative disorders with aging (Butterfield &
Kanski, 2001). The investigators measured protein carbonyls (protein oxidation), 3nitrotyrosine levels, and 4-hydroxynonenal levels (lipid oxidation) in the brain tissue of
mice that were injected 72 hours prior to excision. In the ADR treated brain tissue there
was approximately a 60% increased expression of protein carbonyls, a 25% increased
expression of 4-hydroxyneonenal, 220% increase in multidrug resistance protein-1, and a
55% increased expression of 3-nitrotyrosine which would suggest the susceptibility of the
brain to oxidative stress (Joshi et al., 2005). The high levels of polyunsaturated fatty
acids, low antioxidant capacity, presence of redox metal ions, and high utilization of
oxygen, increases the vulnerability of the tissue. In addition, oxidative stress induced by
ADR in the brain could cause damage to proteins critical for cell functioning, possibly
leading to cell death. Finally, the investigators concluded that ADR, its metabolites or
downstream sequelae is likely to enter the brain and increase oxidative stress, which is
likely to contribute to CRCI.
Madhyastha, Somayaji, Rao, Nalini, and Laxminarayana-Bairy (2002) examined
the effects of intracerebroventricular dosages of methotrexate on cognitive dysfunction in
Wistar rats at various dosages; specifically 3, 4, 5, or 6 mg/kg of body mass depending on
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group randomization for acute toxicity testing. Behavior during an avoidance task, as
well as a dark/bright arena task was then observed follow four hours of monitoring for
gross behavioral alterations. The acute observances were as follows: convulsions,
hyperactivity, grooming, sedation, hypothermia, and increased respiration (Madhyastha et
al., 2002). A 16% mortality rate was observed among rats that were administered 6mg/kg
dosages of methotrexate. During task performance assessments, two groups were
administered chemotherapy; one at 1.5mg/kg and the other at 2 mg/kg. Significant
reductions in task performance [line crossings in dark area (p < 0.01), line crossings in
bright area (p < 0.05), and time spent in dark area (p < 0.01)] were witnessed in rats that
were treated with 2mg/kg of methotrexate as compared to the non-treated rats across five
days of testing. The investigators noted that results suggest drug-related disruptions in
exploratory and locomotor activity. Scores on task retention significantly increased as the
dosages increased, indicating dose-dependent toxicities. There were significant declines
in hippocampal brain amines, as quantified by high pressure liquid chromatography
(HPLC). Dopamine was the most significant [1.5mg/kg (63.2 ±3.6ng/g), 2 mg/kg (61.5
±1.8), p < 0.01] then serotonin [1.5mg/kg (150.7 ±4.9ng/g), 2 mg/kg (150.4 ±3.7ng/g), p
< 0.01] followed by norepinephrine [1.5mg/kg (136.5 ±5.6ng/g), 2 mg/kg (136.0
±6.7ng/g), p < 0.01] when compared to the control group. The investigators noted
significant decreases in overall number of neuroglial cells and neurons in the CA-3 and
CA-4 hippocampal regions of the brains. The loss of physical number of neurons,
behavioral and learning impairment, and depletion of hippocampal brain amines led the
investigators to suspect direct neurotoxicity as a strikingly likely factor. Foley, Raffa, and
Walker (2008) examined the combined effects of 5-FU and methotrexate on memory and
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learning acquisition in a mouse model. The greatest dosages administered were 32mg/kg
for methotrexate, and 75 mg/kg for 5-FU across the two-day study. The results indicated
that the 5-FU alone at 75mg/kg significantly (p < 0.05) increased latencies versus
controls for retrieval of behavioral responses that were previously learned. The combined
administration of 5-FU and methotrexate significantly increased adjusted latencies. The
combination of administered drugs during this study elicited profoundly negative effects
on retrieval and retention tasks. The effects appear to be a more selective disruption in
learning and memory processes.
Determining the mechanisms that underlie the problem of CRCI has yet to be
accomplished. Konat et al. (2008) reported that cognitive dysfunction, particularly
attention and memory deficits, have been observed in upwards of 75% of cancer patients
who have undergone chemotherapy. The investigators sought to determine whether CRCI
was attributable to the malignancy itself or the chemotherapy. ADR was administered to
rats four times (one per week) at a dosage of 2.5mg/kg, while cytoxan (CTX) was
administered at 25mg/kg for a period of four total doses; again once per week. The rats
were subjected to 30 minutes of open field testing comprised of hind leg rearing and line
crossings within a lined black box. They were also subjected to a passive avoidance test
in which they were placed in a lit box and were timed on their latency of entering the
darkened box from the lit box. There were undesirable effects of chemotherapy on
integrity of higher brain functioning. Chronic administration of commonly used
chemotherapeutic agents and the combination of ADR and CTX significantly impaired
short-term memory function. However, these ADR and CTX cocktails may not
substantially hinder or impair long-term memory functioning (Konat et al., 2008). In a
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study conducted on primates, Bourke, West, Cheda, and Tower (1973) examined the
effects of 5-FU administration and diffusion into cerebral spinal fluid (CSF).
Examination of bilateral perfusion in overexposed cerebral cortex or vertebral cisternal
perfusion demonstrated that 5-FU crosses the blood brain barrier. In addition, the
investigators explained that 5-FU may be a useful drug to combat tumors that invade
central nervous system structures. Furthermore, because of the exceptional ability of 5FU to access the brain, oncologists should demonstrate caution with administration.
Chemotherapy-related cognitive impairment has also been reported to be possibly
affected mechanistically by altered primary sex hormones, telomere shortening, bloodbrain barrier disruption, cytokine dysfunction, and genetic susceptibility (Ahles &
Saykin, 2007). On a single-trial step-down inhibitory avoidance protocol, Liedke et al.
(2009) examined the effects of a single bolus dosage of DOX in Wistar rats at increasing
levels similar to those given to humans (.5mg/kg, 2mg/kg, and 8mg/kg). Prior to training,
DOX was administered. Training consisted of a fear-motivated hippocampal memory
dependent protocol where animals learned to associate training apparatus locations with
electric shock to their feet. On day one and day seven, assessments of cognitive function
were administered via retention test trials that were identical to training except for the
lack of electric shocks to the feet. It was determined that a single dose of DOX did not
cause permanent brain damage, which was indicated by improvements in the DOX group
seven days later. In addition, the investigators suggested that a single dosage of DOX
produces reversible memory acquisition impairment but not memory consolidation.
Winocur et al. (2006) examined the effects of a combination of two anticancer
drugs, methotrexate and 5-FU on cognitive function in a mouse model. The investigators
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used the Morris Water Maze Test of spatial memory, which has been reported to be
sensitive to hippocampal dysfunction. Secondly, mice were also administered a nonspatial test of memory in which a discrete cue signaled the location of the submerged
platform in the water. These were followed by a test of Non Matching to Sample rule
learning, which is highly sensitive to frontal-lobe dysfunction. Mice were either injected
with 37.5mg/kg methotrexate and 75mg/kg 5-FU or comparable amounts of saline
solution and were comparable to human dosages and schedules. The results indicated that
learning and memory impairment were significantly associated [trials 18.9 ± 7.7 (drug)
vs. 14.2 ± 8.5 (control), p < 0.05, and errors 20.5 ± 10.1 (drug) vs. 14.9 ± 6.8 (control), p
< 0.05] with treatment of 5-FU and methotrexate, a widely used combination of drugs in
the treatment of breast cancer. Drug induced deficits were observed in tests of spatial
memory and conditional rule learning. However, there were no significant differences
between drug and control groups on cued memory or discriminate learning.
Vascular proliferating cells within the dentate gyrus in the hippocampus have
been associated with neurogenesis, neuronal proliferation, differentiation, and have been
reported to be involved in learning and memory. Mustafa et al. (2008) reported that these
brain regions require brain-derived neutrotrophic factor (BDNF) to aid in the process of
neurogenesis. The researchers examined the effect of 5-FU on spatial working memory as
modeled by a location recognition test in rats. Vascular-associated proliferating cell
numbers and changes in neutrotrophic and neurogenic proteins were also measured. The
object location task was determined by the amount of exploratory time each rat spent
licking, sniffing, chewing, or moving while directing their nose toward an object. Objects
were then randomly rearranged. The rats received 5 injections of 5-FU at 20mg/kg over
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the course of 12 days. Indicative of unaffected spatial working memory, control animals
proceeded to explore novel locations of objects as much as 14% greater amounts of time
than treated rats. There was no significant difference witnessed between exploratory
times of novel and familiar locations in 5-FU treated rats. The investigators also
suggested that treated rats were unable to discriminate between objects in novel locations
and familiar ones when compared to controls. There were no significant alterations
observed in proliferating cell counts. However, there was an approximately 50%
reduction in BDNF. These deficits may suggest structural changes or alterations in the
hippocampus and potentially alterations in neurogenesis.
In an examination of a standard breast cancer therapy protocol, Macleod et al.
(2007) examined the effects a combined cyclophosphamide (40mg/kg) and DOX
(4mg/kg) treatment regimen on ovariectomized rats for three weeks. Rats were treated
once a week with chemotherapy. The investigators implemented a fear-type experiment
which examined learning following treatment. The training consisted of a standard
operant conditioning apparatus which audible tones were paired with mild shocks to their
feet. The investigators noted that significant impairments in contextual fear memory were
observed, suggesting detrimental effects on the hippocampal-related learning and
memory (Macleod et al., 2007).
In a longitudinal study Schilling, Jenkins, Morris, Deutsh, and Bloomfield (2005)
administered cognitive assessments on 50 patients who had undergone chemotherapy at
six and 18 month intervals. A wide array of cognitive assessments were administered
which included: measures of verbal memory (WMS logical memory, AVLT recall 1-7),
visual memory (complex figure, copy, immediate and delayed recall), executive function
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(Stroop Task), working memory (spatial span, letter/number sequencing, digital span),
FSIQ estimate (national adult reading test), processing speed (letter cancellation task),
and self-report [cognitive failures questionnaires, GHQ12, FACTB, ES, F (patients only)].
The three measures that showed significant group by time interaction were: the AVLT
supraspan, total recall, and the WMS letter number sequencing task. All three require a
high degree of concentration and attention, precisely the function that patients complain
about the most (Schilling et al., 2005).There were significant differences observed
between patients who had undergone chemotherapy compared to apparently healthy noncancer controls. The results also indicated a group by time interaction for three measures
of verbal and working memory. The investigators speculated that the neurotoxic effects
observed during cognitive assessments may be indicative of direct neurotoxicity.
In addition, female cancer survivors of menopausal age may be at greater risk of
CRCI considering the modifications of hormonal levels. In particular, Schilling et al.
(2005) indicated that menopausal females undergoing hormone therapy in addition to
receiving chemotherapy may be at a significantly greater risk for CRCI. Lastly, the
investigators noted that QOL, anxiety, and fatigue can be affective of cognitive
functioning, although patients undergoing chemotherapy were 2.3 times more likely to
show cognitive impairment than the control group. The investigators suggested that while
low dosages of chemotherapy, as expressed in the self-report portion of the patient
evaluation, may not induce noticeable impairment, it should be expected that greater
doses may cause more severe and lasting impairments.
Life decisions regarding career and educational choices may be profoundly
affected by the negative side-effects of chemotherapy on memory and concentration.
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These decrements may also have an effect on general QOL (Mitchell & Turton, 2011).
Four cancer patients were interviewed, and their experiences with CRCI and QOL
measures were recorded. Reduction in the ability to make smooth transitions back to
activities of daily living, such as returning to work, may persist long after treatment is
completed (Carlsson et al., 2000; Schilling et al., 2005). With the difficulties that patients
face along the cancer continuum, Mitchell and Turton (2011) suggested that on average,
patients were significantly less likely to share their experiences with cancer to their
healthcare provider than to fellow cancer survivors. In addition, they suggested that
healthcare providers should educate their patients about the potential sequelae of side
effects they may experience as they complete treatment, especially with the incidence of
cognitive dysfunction. If patients were more aware of the negative effects of CRCI, they
may be more encouraged to report incidences to their healthcare provider.
Exercise Benefits in a Cancer Population
Physical activity and cognitive function are important to QOL as well as overall
health, and are vitally important to the reduction of disease impact and maintaining a
healthy cognitive function. Wood, Alvarez-Reyes, Maraj, Metoyer, and Welsh (1999)
investigated self-reported physical fitness, QOL, visual acuity, and cognitive function on
two separate occasions within a two week period of time and determined that increased
physical and cognitive function was significantly related to observed increases in QOL
scores among older adults. In pre-adolescent school-based academic performance,
Hillman et al. (2009) examined the effects of walking during a 20-minute Balke treadmill
protocol on neurological and behavioral indices on aspects of cognitive control and
attention. The investigators found that a single, moderately intense acute bout of aerobic
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exercise may improve attention, cognitive control, and academic performance in preadolescent children.
During the past few decades, advances in health care and treatment of various
diseases have been a factor in healthcare cost increases. Considering resource and
financial limitations, interventions aimed at the improvement of overall health should
lead to maximal health benefit utilizing as minimal of an amount of resources as possible.
In oncology, advances in treatment have prolonged life expectancy. With increasing life
expectancy for cancer survivors, the chances of increased amount of treatment-related
side effects also become more pronounced. In a review of literature, Roine et al. (2009)
examined 61 studies reporting on the cost effectiveness of exercise-based interventions
and the treatment of various diseases. Although some of the research presented minor
conflicting arguments as to the efficacy of certain exercise interventions, the overall
results indicated that exercise is a cost effective method of healthcare.
It has been well established that exercise has been positively associated with
increases in cardiovascular function, resting heart rate, pulmonary function, forced vital
capacity (FVC), upper-body muscular endurance, lower-body muscular endurance, core
muscular endurance and flexibility, improvements in body composition, as well as
reductions in behavioral, sensory, affective, cognitive, mood, and total fatigue scores
(Fong et al., 2012; Hsieh et al., 2008; Schneider, Hsieh, Sprod, Carter, & Hayward,
2007a; 2007b; 2007c; Van Weert, et al., 2010). In addition, exercise has been linked with
reductions in inflammation (Fairey et al., 2005). Furthermore, individualized cancer
rehabilitation interventions have been shown to increase five-year survival rates
(Peterson, Repka, Hayward, & Schneider, 2010).
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Cognitive Training
The term brain plasticity refers to the inherent capacity of the brain itself to
respond to physical and functional changes (Mahncke et al., 2006). Brain function can be
strengthened or degraded, depending on the circumstances. Manipulating learning
context can alter plasticity that can be both positive and negative, which would imply that
physical, environmental, and behavioral stimuli may strengthen or degrade brain function
across the aging process. Manipulation of learning context can also alter plasticity.
Stimuli leading to positive plastic changes may be a fundamental tenet of cognitive
therapy to help restore memory, cognitive, motor, and sensory cognitive functions. In
recent years, brain training software packages have gained momentum in sales and
notoriety. One commercially available program, Brain Fitness® by Posit Science®,
consists of progressive online cognitive exercises designed to enhance “brain plasticity”
(Smith et al., 2009). Mahncke et al. (2006) reported that training brain plasticity utilizing
appropriately designed training archetypes may substantially improve function and
recovery from losses in sensation, cognition, memory, and motor control. In addition, this
process should be initiated early in the aging process to enhance brain health and
cognitive fitness before significant losses develop but also could be effective later in the
aging process when significant losses have already emerged. Furthermore, the
investigators noted that when a clinically validated model is available, this scientifically
based approach unambiguously targets the primary causes of cognitive decline associated
with aging, this could revolutionize therapeutic techniques for aging adults.
The demand for delaying or preventing age-associated declines in older adults has
been steadily increasing. Designing and implementing cost effective alternatives to
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standard care may be beneficial for the reduction of the need for home care, nursing
homes, and hospital stays, and therefore reduce health care costs. Ball et al. (2007)
evaluated the associations between three Advanced Cognitive Training for Independent
and Vital Elderly (ACTIVE) interventions (memory, reasoning, and speed of processing
training), in a sample of 2802 independently thriving older adults. This training was
aimed to improve mental abilities as well as daily functioning. Research has indicated in
human and animal populations that neural plasticity endures across the lifespan, and that
cognitive stimulation in the environment is an important predictor of enhancement and
maintenance of cognitive functioning. The investigators noted that limited education is a
risk factor for dementia. Primary and secondary follow-up analyses indicated significant,
immediate gains on cognitive outcomes in all groups except the no contact control.
Eighty-seven percent of speed-trained, 74% of reasoning-trained, and 26% of ACTIVEtrained participants demonstrated reliable improvement on the pertinent cognitive
composite immediately following intervention. Furthermore, the proximal effects
occurred and continued throughout the following 24-months, further implying that
cognitive training may have residual effects that may have prolonged improvements.
Finally, those who participated in booster training showed improved gains (speed-92%
vs. none-68%; reasoning-72% vs. none-49%) beyond normal cognitive training.
In breast cancer patients who were about to receive chemotherapy, Wefel,
Saleeba, Buzdar, and Meyers (2010) examined cognitive functioning to gauge levels of
preexisting dysfunction. In particular, measures of affective status, cognitive function,
and QOL were measured prior to administration of treatment, during treatment, and
directly following treatment. Prior to treatment, approximately 21% of the sample
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displayed evidence of cognitive dysfunction. In addition, older patients appeared to be at
a greater risk of displaying evidence of cognitive dysfunction. The investigators noted
that approximately 65% (during and following treatment) of the sample exhibited acute
declines in cognitive function. Learning, executive function, memory, and processing
speed were domains of cognitive function that were most affected by chemotherapy
treatment. There were no significant differences between patients exhibiting acute
cognitive decline and those who did not decline on any clinical, demographic, or mood
variable. Sixty-one percent of the sample exhibited late decline (one year) in cognitive
function with 30% of the sample demonstrating new onset of cognitive dysfunction that
was not present beforehand. The investigators concluded that the impact of diminished
brain/cognitive reserve may play a substantial role in the vulnerability and failure to fully
recover from acute treatment-related changes in cognition and/or the development of late
cognitive decline of post chemotherapy patients.
Reduction of disease impact and conditions generally affecting older population
has become increasingly important. Exercise and maintaining a healthy level of cognitive
function have become methods that have been progressively more supported. Elements of
cognitive functioning are considerably connected to overall health and QOL (Wood,
Alvarez-Reyes, Maraj, Metoyer, & Welsh, 1999). Wood et al. (1999) tested pre versus
post levels of physical fitness, cognitive function, visual acuity, and QOL during a twoweek intervention in 44 older adults. The investigators then examined the relationships
between values of physical fitness against the aforementioned variables. It was
determined that there were significant relationships between QOL, physical fitness, and
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cognitive function. It may be that greater levels of physical fitness and cognitive function
lead to increased QOL scores in older adults.
Decrements in cognitive performance have also been observed in individuals
undergoing treatment for high grade gliomas. Hassler et al. (2010), in a pilot study,
examined the effects of ten weeks of cognitive training on 11 patients with high grade
gliomas. The training intervention consisted of ten weekly group meetings consisting of
90 minutes of holistic mnemonic training that encompassed attention, memory, and
verbal skills. Cognitive function testing was completed before and following completion
of the training intervention. Specifically, the Controlled Oral Word Association Test
(COWAT) for verbal acuity, Trail Making Tests A and B for executive function and
visual motor speed, and the Hopkins Verbal Learning Test (HVLT) for verbal memory
were implemented. Hassler et al. (2010) speculated that the location of the tumor in high
grade glioma patients may compound the effect of CRCI because of the location of the
tumor being located within the brain or spine. There were improvements observed in all
cognitive measures however, significant improvements were only detected during the
HVLT (score 19.6 ± 8.9- baseline, 23.6 ± 8.8-12 weeks, p < 0.05) assessments. The
investigators also noted that this pilot work demonstrated that patients with central
nervous system tumors can not only tolerate the stress of training, but they also can
improve on measures of cognitive functioning.
In a combined assessment of Memory and Attention Adaptation Training
(MAAT), Ferguson et al. (2007a) assessed cognitive function via assessment of multiple
cognitive and behavioral components on 29 breast cancer survivors who had recently
completed treatment. The MAAT was composed of education on memory and attention,
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self-awareness, self-regulation focusing on reduction of arousal through relaxation
training, activity scheduling and pacing, and training of cognitive compensatory
strategies. The MAAT interventions were implemented once a month for four months.
Prior to and following interventions participants were tested via the following for
cognitive functioning: The California Verbal Learning Test-II, Logical Memory I and II
from Weschler Memory Scale, Digit Symbol Subtest from the Weschler Adult
Intelligence Scale III, Trail Making tests A and B, and the Stroop Color-Word
Interference Test. The results indicated that participants significantly (p < 0.05) improved
from pre to post for cognitive functioning in a daily life setting for all participants.
Quality of life, as measured by the Quality of Life-Cancer Survivors Scale (QOL-CS),
also revealed significant improvements from pre to post intervention.
In a sample population of cognitively healthy, well-educated older adults near the
age of 75, Smith et al. (2009) evaluated the effects of cognitive training on cognitive
function using the Posit Science® Brain Fitness® program. Participants were either
randomized into the experimental cognitive training group or were randomized as active
controls and were given content-oriented coursework that required an equivalent amount
of time as the cognitive training group. The results indicated that there were significant
improvements on auditory processing speed (3.9 points vs. 1.8 points, p < 0.05), and
small but statistically significant benefits on memory performance for the group using the
Posit Science® Brain Fitness® program (99.6 ± 14 to 103.8 ± 14). The investigators
explained that this type of cognitive training software has been developed to focus
improvement on central auditory system speed and accuracy. In addition, the training of
neuromodulatory systems may positively impact generalized benefits in measures of
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memory and attention greater than general cognitive simulation. Smith et al. (2009)
added that brain plasticity-based training may develop information flow through language
and auditory pathways in the brain that can possibly translate training benefits to nontrained tasks and that training based improvements may endure following training
completion.
Wolinsky, Unverzagt, Smith, Jones, Stoddard, and Tennstedt (2006) examined the
ability of three ACTIVE cognitive training interventions (memory, reasoning, and speed
of processing). Health-related QOL (HRQOL) was measured using a test consisting of
eight 36-item health surveys (SF-36). At two years’ post training, 24% and 37% had
clinically relevant drops on ≥ 4 and ≥ 3 SF-36 scales. At five years’ post training, 33%
and 47% had clinically relevant drops on ≥ 4 and ≥ 3 SF-36 scales. Participants in the
speed of processing intervention were significantly less likely to have extensive HRQOL
decline compared to participants in the control group regardless of the threshold or time
period, whereas participants in the memory and reasoning intervention were significantly
less likely to have HRQOL decline only at five-years post-training and only at the lower
threshold. The effect of the speed of processing intervention was stronger and evident
earlier than those for the memory and reasoning interventions. The result stems from the
speed of processing intervention being the most procedural intervention, operating
through sensory-motor elaboration and repetition, bringing about a broader pattern of
regional brain activation. At five years’ post-training, however, all three interventions
were successful in protecting against a lower threshold of age-related extensive declines
in cognitive function. Older adults face declining cognitive ability and increasing
difficulty with activities of daily living.
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Physical Activity and Cognitive Function
In a longitudinal study consisting of healthy older adults, Barnes, Yaffe, Satarino,
and Tager (2003) examined cardiorespiratory fitness at baseline and compared the
association between those values and cognitive function over the course of six years.
Cardiorespiratory fitness may provide a means to bridging the gap between cognitive
function and history of physical activity because it is largely determined by habitual
physical activity and is based on objective physiological measurements (Barnes et al.,
2003). The investigators hypothesized that baseline measures of cardiorespiratory fitness
would be associated positively with maintenance of cognitive function over time and with
levels of cognitive function at follow-up. The results indicated that cardiorespiratory
fitness was positively associated with preservation of cognitive function over a six-year
period. Participants with worse cardiorespiratory fitness at baseline experienced greater
decline percentage on the MMSE over six years 95% CI [lowest 0.5 (0.8-0.3), global
score-28.5 (28.3-28.7), middle-0.2 (0.5-0.0), global score-28.9 (28.7- 29.1), highest-0.0
(0.3-0.2), global score-29.2 (29.0-29.5) p < 0.01]. After adjustment for demographic and
health-related covariates, baseline measures of cardiorespiratory fitness were also
positively associated with performance on cognitive testing conducted 12 years later. The
association between cognition and cardiorespiratory fitness was the most robust for
measures of attention/executive function and global cognitive function. It is possible that
fitness has a more pronounced effect on the frontal lobes, which the investigators
suggested mediates attention/executive function (Barnes et al., 2003). It is also possible
that cardiorespiratory fitness is a better marker of underlying health status, which is
associated with cognitive function over time. The investigators concluded that
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participants with greater baseline levels of cardiorespiratory fitness experienced cognitive
decline to a lesser extent over the course of 12 years following completion of the study.
This suggests that maintaining high levels of cardiorespiratory fitness may help provide
long-term protection against cognitive dysfunction in older adults.
There appears to be a universal acceptance of the fact that exercise on a regular
basis has benefits for muscular strength, cardiovascular fitness and function, management
of weight, metabolic health, disease prevention, bone mineral density, disease
management and prevention, as well as decreases in mortality; however, much less is
known about the brain and the effect of exercise upon it (Zoeller, 2010). In a review of
literature, Zoeller (2010) described aging as being accompanied by varying degrees of
decline in cognitive function declination. In particular, processing speed, memory, and
increases in risk of dementia and Alzheimer’s disease have been linked to age-related
cognitive decrements. Physical performance and speed of gait were indicated to be
predictors of dementia in individuals with or without baseline levels of cognitive
impairment. Large improvements in certain measures of cognitive function such as,
auditory attention, delayed memory and motor function have been linked to interventions
with results indicating improvements in aerobic training interventions. Lesser
improvements in aerobic interventions have been associated with cognitive speed and
visual attention improvements. Exercise was most significantly related to executive
function improvements as opposed to any other measure of cognitive function. In
addition, habitual exercise has been associated with neurogenesis, enhanced central
nervous system metabolism, improvements in memory and angiogenesis, as well as
attenuation of the age-related brain volume, structure, and density losses (Zoller, 2010).
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Acute bouts of moderate exercise have also been indicated to positively affect
outcomes of memory in circadian rhythm altered shift workers. Potter and Keeling (2005)
hypothesized that acute bouts of moderate intensity exercise would improve memory
ability to encode and recall words in a 15-item list. The second portion of the study was
to examine whether circadian rhythms in memory performance might interact with the
exercise intervention to produce different levels of performance change at different time
of day for 31 male shift workers, working at all hours of the day. Following each exercise
trial there were significant increases (approximately 8, 10, 12, 13, 14 words per trial, p <
0.01) on overall number of words recalled. There was also a significant interaction with
exercise and time of day, in addition to the exercise intervention and average number of
recalled words. This would suggest that moderate, short term; intensity exercise may be
beneficial for memory function and may significantly reduce the effects of daytime
circadian rhythms on memory performance.
Lautenschlager et al. (2008) examined the effects of a 24-week physical activity
intervention consisting of at least 150 minutes of moderate intensity activity per week in
older adults exhibiting objective or mild cognitive impairment. Prior to the exercise
intervention, all participants were assessed via Alzheimer Disease Assessment Scale
(ADAS-Cog). This assessment consists of 11 brief cognitive tests assessing memory,
language, and praxis. All participants chose to do walking or some other form of aerobic
activity as well as some strength training. Participants were outfitted with a pedometer to
help monitor progress each week. The results indicated during follow-up assessments of
cognitive function that older adults in the exercise group performed to a greater extent
during measures of delayed memory recall. In addition, those in the exercise group
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showed better delayed memory recall. In summary, this study demonstrated that aerobic
exercise improves cognitive function in older adults with subjective and objective mild
cognitive impairment.
In a progressive aerobic only intervention, Masley, Roetzheim, and Gualtieri,
(2009) examined the effects of a ten-week progressive aerobic intervention on cognitive
function. The cognitive function measures were: mental speed, memory, reaction time,
attention, and cognitive flexibility. The investigators indicated that those who were in the
aerobic training groups had significantly (p < 0.05) greater percentage scores on memory
(2.8), mental speed (5.2), reaction time (5.1), attention (45.9), and cognitive flexibility
(31.7), which is a measure of executive function. Of interest is that the investigators
mentioned that those individuals who were more aerobically active during the week had
significantly greater scores than those who were less aerobically active during the week.
The investigators suggested that these positive effects on neurocognition may be doseresponse dependent.
In a 12-week mental and physical intervention, Barnes, Santos-Modesitt, Poelke,
Kramer, Castro, Middleton, and Yaffe (2013) examined the combined effects of mental
activity in addition to physical activity on measures of cognitive function in older adults
who were considered inactive. Participants were assigned to groups that were involved
with home-based mental activity (Posit Science®, or educational DVDs) and/or classbased physical activity, and the group combinations therein. A stretching and toning
based control was also utilized to compare group differences. The investigators found
that cognitive scores on a global scale significantly improved over time. However, those
who participated in the mental activity training (Posit Science®) did not significantly

49
differ from those who were in the mental activity control group that watched educational
DVDs. The results indicated that although the groups that participated in mental activity
training improved on measures of cognitive function, there were no significant
differences between those who used PositScience® or the educational DVD’s. The
investigators concluded that amount of mental activity may be a greater factor than the
type of mental activities.
Within the literature it is apparent that cancer treatment(s) devastate not only
cancerous cells in the body, but to varying degrees across treatments, cancer types, and
stage of cancer have been observed to negatively and destructively affect healthy cellular
tissue. Whether it be inflammatory toxicity, micro-vascular toxicity, or direct neurotoxicity; the implementation of combative measures, with the purpose of treatmentrelated side-effect reduction, or alleviation is of importance. Cancer incidence has been
reported to be increasing which may also signify an increasing amount of prescribed
treatments. Although, following treatment people are also living longer, which suggests
potentially greater incidence of treatment-related side-effects. Unaccompanied, research
has indicated the benefits of exercise and cognitive training on physiological,
psychological, and cognitive variables. Implementing combined regimens of aerobic and
cognitive training may be a substantially greater method of treating the treatment
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CHAPTER III
METHODS
Experimental Design
The intervention consisted of 12 weeks (or 36 sessions) of aerobic, cognitive, or a
combination of aerobic and cognitive training on the Motion Fitness Brain-Bike®. This
study provided allowance for the investigation of the implications of cognitive and
aerobic training on physiological and psychological parameters in cancer survivors who
were undergoing, or underwent treatment. Participation in this study was according to
pre-determined inclusion and exclusion criteria. In addition, participants were screened
for any secondary factors such as medication(s) or physical limitations not included in
inclusion/exclusion criteria, but that could have potentially altered the outcomes of the
study. Selection of CAN participants was conducted during or following initial physical
assessment. Selection of NC participants was via email listserv and university-related
recruitment websites. In certain circumstances where offsite recruiting resulted in
participants expressing interest in this study, selection may have occurred prior to initial
physical assessment. In depth cognitive and psychological assessment parameters
included: general cognitive functioning, processing speed, working memory, executive
function, attention, verbal learning and memory, verbal fluidity, perpetual reasoning,
mood, anxiety, depression, fatigue, and QOL.
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Medical history, fatigue, depression, mood, and anxiety information was collected
prior to initial assessment. Comprehensive cognitive assessment data were gathered prior
to and following the exercise intervention, and have been explained in detail in the
cognitive assessment section. Physiological baseline measures were gathered prior to and
following the exercise intervention, including the assessment of peak aerobic capacity
(VO2peak). Further details have been included in the subsequent physiological assessment
section.
Participants
Participants in this study were males and females (56.9 ± 8.8 years of age), who
had been diagnosed with cancer (CAN) (n = 28) and age-matched participants who had
not been diagnosed with any type of cancer (NC) (n = 7). Individual group stratification
abbreviations are listed in Table 1. Participants who had cancer, were either undergoing,
or had underwent chemotherapy or chemotherapy and radiation treatment, and were
referred to the RMCRI from local oncologists. Following physician referral to the
RMCRI, participants were asked to read and complete the following paperwork required
for pre-screening: complete medical history, cardiovascular disease risk assessment,
cancer history, and a lifestyle/activity evaluation. All of the aforementioned paperwork
items were evaluated prior to initial assessment for potential limitations or co-morbidities
that might have affected the outcomes of the study. Lifestyle factors such as, tobacco,
alcohol, dietary intake have been highlighted through questioning on the lifestyle/activity
evaluation. Participants were informed on the overview of the procedures and purpose as
explicitly delineated within the informed consent (Appendix A).
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Participants were then asked to read and sign the informed consent form. Pending
acceptance of terms and conditions of the study as well as complying with
inclusion/exclusion criteria as described in the following paragraph, participants were
then randomized into one of five groups as described in Table 1. The CAN-AER-COG (n
= 9) group was composed of cancer survivors that participated in aerobic, cognitive, and
flexibility training. The CAN-AER group (n = 7) was composed of cancer survivors and
participated in aerobic and flexibility training; however, they did not participate in
cognitive training. The CAN-CON group (n = 7) was composed of cancer survivors that
participated in flexibility training, but did not participate in aerobic or cognitive training.
The NC-CON group (n = 7) was the control group consisting of participants who had not
been diagnosed with any form of cancer. The NC-CON group completed aerobic,
cognitive, and flexibility training. The CAN-COG group (n = 5) was composed of cancer
survivors who participated in cognitive training and flexibility training; however, they did
not participate in aerobic training. This study followed and abided by guidelines
established by University Institutional Review Board following approval (Appendix B).
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Table 1
Group stratification
Group

Participants

Aerobic

Cognition

Flexibility

1
CAN-AER-COG

Cancer

Yes

Yes

Yes

2
CAN-AER

Cancer

Yes

No

Yes

3
CAN-CON

Cancer

No

No

Yes

4
NC-CON

No Cancer

Yes

Yes

Yes

5
CAN-COG

Cancer

No

Yes

Yes

Figure 1. Experimental Design. CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls.
CAN groups, n = 28; CON group, n = 7.
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Inclusion/ Exclusion Criteria
Participants in the study were excluded from the study if they reported having any
history of psychiatric diagnoses, neurological disease, past or present alcohol or
substance abuse, difficulty with mobility, auditory dysfunction, and non-corrected visual
issues. Participants were not allowed to partake in the study if they had undergone any
type of software based cognitive training in the past 6 months including: Neuro-Active®,
Posit-Science®, Mindfit®, Lumosity®, My Brain Trainer®, or any other brain fitness
program. It was also a preliminary requirement that participants be right handed because
the mechanical design of the original Brain Bike® mouse pad assembly only allowed for
individuals who were right handed, however in 2013 our lab acquired a second Brain
Bike® which had a detachable mouse pad assembly which could be moved from the right
side of the Brain Bike® to the left side allowing for left hand dominant individuals to be
included. Participants were told they could not have participated in any type of aerobic
activity such as walking or running greater than two times per week for eight weeks prior
to starting the study. Participants were also required to score greater than or equal to 26
on the MMSE, had been undergoing, or had completed chemotherapy within eight weeks
of starting the study, or completed the combination of chemotherapy and radiation
treatments, in upwards of six years.
Physiological Assessment
Following the completion of preliminary paperwork, participants completed a
physical examination for clearance to exercise. Initial values for heart rate (HR), blood
pressure (BP), oxygen saturation (SpO2), height, weight, body composition,
circumference measurements, cardiovascular fitness (VO2peak, RMCRI protocol), balance
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(Bertec Balance Screener or Unipedal Stance Test), pulmonary function (Spirometry),
estimated 1RM (Brzycki equation), muscular endurance (plate loaded cable assisted
machines), handgrip dynamometry, abdominal muscular endurance (plank test), and
flexibility measures (Modified Sit and Reach and Shoulder Reach Behind Back) were
determined and recorded as part of the standard RMCRI physical assessment protocol.
Since this study was conducted over a period of nearly four years, certain procedural
changes were introduced that altered some components of the overall RMCRI
assessment. These include additions or removals of the following: Unipedal stance test,
Bertec balance screening, circumference measures, crunch test, plank test, shoulder reach
behind back test, muscular endurance via (plate loaded cable assisted machines),
estimated 1RM and the waist-to-hip ratio measures and data collected had varying values
for the aforementioned, and therefore could not be included in analyses. For the purposes
of this evaluation, descriptions and analyses concerning anything other than measures of
HR, BP, cognitive function, VO2peak, and Modified Sit and Reach were conducted during
pre and post assessments, but have been purposely excluded from this evaluation. Any
other relevant information regarding currently existing medical conditions, over the
counter, and prescription medications, was evaluated in the context of the study
parameters.
Blood Pressure, Heart Rate,
and Pulse Oximetry
Initial resting values of blood pressure (BP) were obtained from subjects via
auscultation methods as outlined in Heyward (2006). Participants were asked to sit
quietly for at least five minutes. With the participant’s arm resting approximately at heart
level the deflated blood pressure cuff was placed around the participant’s bare arm and
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attached via Velcro® strapping. The placement of the blood pressure cuff was secured
approximately one inch above the antecubital fossa. The manometer was positioned so
that the center of the dial was visible at the eye level of the assessor. The head of the
stethoscope was placed approximately one centimeter medial and superior to the
antecubital fossa over the brachial artery. Following the asking of each client what his or
her typical systolic blood pressure was, the assessor closed the valve and steadily and
rapidly inflated the cuff air bladder to approximately 30mmHg above the client reported
values. If the values that the client reported were not sufficient to result in an accurate
measure of blood pressure, the assessor re-inflated the cuff to a value great enough to
produce accurate assessments of blood pressure. The assessor then slowly opened the
valve to reduce air pressure and listened for phase I of the Korotkoff sounds. Phase I
sounds have been reported to equate to systolic pressure (Hayward, 2006). Pressure
reduction continued while listening for phase IV and V. Phase V is generally considered
as equating to diastolic blood pressure. The assessor continued deflating the pressure in
the cuff until the complete cessation of audible sounds occurred. A minimum of 30
seconds was allowed between each measure of BP as recommended by Heyward (2006).
Measures of BP were recorded on assessment data collection sheets with the average of
the two measures chosen as the final value. In addition, percentage of O2 bound to
hemoglobin was measured via pulse oximetry.
Assessment of Cardiorespiratory
Fitness
The RMCRI treadmill protocol was administered to evaluate each participant’s
cardiorespiratory fitness (CF). In 2010, this progressive treadmill protocol was designed
specifically for cancer survivors. Participants were made privy to all elements of the
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pending treadmill testing prior to commencement. If health-related concerns presented
themselves that would have inhibited the participant from executing an appropriate
performance during the advancement of the initial assessment, then secondary measures
of CF such as, submaximal cycle-ergometer testing measures would have been employed.
However, no such circumstances presented themselves during the course of this study.
The RMCRI protocol was carefully monitored and administered. Each stage was
one minute in length with the intensity adjusted as a means of belt speed, incline, or both
each successive minute. Stage one walking speed started at 1.0 mph and was increased by
0.5 mph until the participant verbalized his/her commitment to aborting the continuation
of the test. During stages one through four, grade consistency was maintained at 0% until
stage five began. The first grade inclination was set to 2% and was maintained
throughout the sixth stage. From stage seven until stage 21 or at the onset of volitional
fatigue, grade and belt speed was increased 1% and 0.1 mph, respectively. HR and SpO2
were recorded each minute while BP and RPE were recorded every third minute until test
completion. Table 2 further details the staging, administration, and determination of
VO2peak for the RMCRI protocol. The test was terminated if the client reached volitional
fatigue, asked to stop for any reason, HR or SBP did not increase as intensity increased,
DBP fluctuated more than 10mmHg from baseline, SpO2 dropped below 80 via pulse
oximetery, and HR exceeded calculated maximum HR determined by the following
formula (HRmax = 205.8 – (.685 x age). The test completion time was measured in
conjunction with age, gender, and whether or not the participant used the handrails.
VO2peak was determined based on these variables. Lastly, table 3 describes how the
classification of CF analogous to the aerobic capacity (mL·kg-1·min-1) was determined.
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Table 2
Estimation of cardiorespiratory fitness (mL·kg-1·min-1)
Estimated VO2 peak
Estimated VO2 peak (H)
S mph
%
METS
(mL/kg/min)
(mL/kg/min)
1
1.0
0
6.2 (walk)
1.7
6.2 (walk)
2
1.5
0
7.5 (walk)
2.1
7.5 (walk)
3
2.0
0
8.9 (walk)
2.5
8.9 (walk)
4
2.5
0
10.2 (walk)
2.9
10.2 (walk)
5
2.5
2
12.6 (walk)
3.6
12.1 (walk)
6
3.0
3
15.9 (walk)
4.5
14.4 (walk)
7
3.3
3
17.1 (walk)
4.9
15.2 (walk)
8
3.4
4
19.1(walk)
5.5
16.6 (walk)
9
3.5
5
21.3(walk)
6.1
18.1 (walk)
23.6
19.7
10
3.6
6
28.0 (run)
8.0 / 6.7
22.8 (run)
(walk)
(walk)
25.9
21.3
11
3.7
7
29.6 (run)
8.5 / 7.4
23.9 (run)
(walk)
(walk)
28.4
23.0
12
3.8
8
31.3 (run)
8.9 / 8.1
25.0 (run)
(walk)
(walk)
30.9
24.8
13
3.9
9
32.9 (run)
9.4 / 8.8
26.2 (run)
(walk)
(walk)
33.5
26.6
14
4.0
10
34.6 (run)
9.9 / 9.6
27.3 (run)
(walk)
(walk)
36.3
10.4 /
28.5
15
4.1
11
36.4 (run)
28.6 (run)
(walk)
10.4
(walk)
39.0
10.9 /
30.4
16
4.2
12
38.2 (run)
29.8 (run)
(walk)
11.1
(walk)
42.0
11.4 /
32.5
17
4.3
13
40.0 (run)
31.1 (run)
(walk)
12.0
(walk)
45.0
12.0 /
34.6
18
4.4
14
41.9 (run)
32.4 (run)
(walk)
12.9
(walk)
48.1
12.5 /
36.7
19
4.5
15
43.9 (run)
33.8 (run)
(walk)
13.7
(walk)
51.3
13.1 /
38.9
20
4.6
16
45.9 (run)
35.2 (run)
(walk)
14.7
(walk)
54.6
13.7 /
41.2
21
4.7
17
48.0 (run)
36.6 (run)
(walk)
15.6
(walk)
Note: (H) denotes the usage of handrails by the participant

METS
(H)
1.7
2.1
2.5
2.9
3.5
4.1
4.3
4.7
5.2
6.5 /
5.6
6.8 /
6.1
7.1 /
6.6
7.5 /
7.1
7.8 /
7.6
8.2 /
8.1
8.5 /
8.7
8.9 /
9.3
9.3 /
9.9
9.7 /
10.5
10.0 /
11.1
10.5 /
11.8
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Table 3
RMCRI cancer-specific cardiorespiratory fitness norms (mL·kg-1·min-1)
Age
Low
Fair
Avg.
Good
Ex.
M ± SD
Women 19-39 < 22.2 22.2 - 25.0 25.0 - 26.6 26.6 - 28.3 > 28.3 26.0 ± 5.6
40-49 < 18.6 18.6 - 22.3 22.3 - 24.5 24.5 - 27.6 > 27.6 23.5 ± 5.5
50-59 < 17.6 17.6 - 21.1 21.1 - 23.4 23.4 - 27.8 > 27.8 22.5 ± 6.3
60-69 < 15.4 15.4 - 17.6 17.6 - 21.3 21.3 - 23.6 > 23.6 19.7 ± 5.6
70+
Men

< 10.9 10.9 - 15.0 15.0 - 16.7 16.7 - 19.2 > 19.2 16.1 ± 5.1

19-39 < 23.9 23.9 - 24.8 24.8 - 25.0 25.0 - 31.7 > 31.7 25.3 ± 5.4
40-49 < 18.5 18.5 - 24.1 24.1 - 29.1 29.1 - 33.0 > 33.0 26.3 ± 6.9
50-59 < 14.5 14.5 - 19.6 19.6 - 23.5 23.5 - 29.2 > 29.2 22.5 ± 7.4
60-69 < 15.7 15.7 - 17.7 17.7 - 23.4 23.4 - 27.9 > 27.9 21.3 ± 6.7
70+

< 13.6 13.6 - 17.1 17.1 - 21.3 21.3 - 24.3 > 24.3 19.2 ± 6.0

Flexibility
In the evaluation of flexibility, the modified sit and reach test was administered.
The modified sit and reach test allows for the determination of flexibility while
controlling for limb length differences between individuals. The participant began the
assessment by first removing his or her shoes and seating themselves on the floor with his
or her head, shoulders, and buttocks placed firmly against a wall, and with his or her legs
positioned straight ahead of them. The sit and reach measurement apparatus was then
placed against his or her shoeless feet with the “zero” end of the measurement arm facing
toward the participant. The participant was instructed to hold his or her arms straight
forward while keeping his or her back, head, and buttocks firmly placed against the wall.
The measurement arm was then moved toward the fingertips of the participant’s extended
arms. Once that measure was secure, the participant was subsequently instructed to reach
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forward as far as possible, pushing the sliding measurement tab as far as he or she could.
The participant was also instructed to keep his or her hands together and knees fully
extended during each trial. The furthest of three trials was considered the final
measurement of flexibility.
Psychological Indices
Before preliminary assessment, and following the completion of the 12-week
intervention, the following indices of psychological assessment were completed: Beck
Depression Inventory, Piper Fatigue Scale, and Ferrans and Powers Quality of Life Index
Cancer Version III. Following antineoplastic treatment, a commonly experienced side
effect is depression.
Beck Depression Inventory
In this study, depression was measured using the Beck Depression Inventory. The
Beck Depression Inventory is composed of 21 items which are declarative statements
analogous to values ranging from zero to three. Statements that reflect values of zero are
indicative of the most extreme positive position. Opposing assertions, valued as three,
indicate the most extreme negative statement. A sense of neutrality exists for values
represented by one and two, although either the three or the zero on the opposing ends of
the continuum may be favored. Values for all 21 items are added; scores range from zero
to 63 with zero indicative of no depression and > 40 reflecting extreme depression
(Salkind, 1969).
Piper Fatigue Inventory
Piper fatigue Inventory results yield an inclusive score, indicating the overall
extent of cancer-related fatigue (CRF). Aspects of participants’ lives that may be
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significantly impaired or hindered by CRF were further delineated using the calculated
values obtained for cognitive/mood, behavioral, affective, and sensory subscales. There
are 22 items in the inventory composed of four subscales as previously mentioned. Each
possible score per subscale ranges from zero to ten. Overall measures of CRF range from
zero to ten and is evaluated from the average of all subscales. A combined score of zero
is redolent of a lack of perceived fatigue. Scores ranging from one-three, four-six, and
seven+ indicate mild, moderate and severe fatigue, respectively (Piper, Dibble, Dodd,
Weiss, Slaughter, & Paul, 1998).
Quality of Life Index
In cancer rehabilitation settings, outcomes on QOL assessments are ideal for
determining efficacy and impact of rehabilitative programs (Ferrans, 2010). Utilizing
Ferrans and Powers Quality of Life Index Cancer Version III, QOL measures were
administered at baseline and at three months following the intervention. Sixty-six
questions are included in this assessment which pertain to the significance and
importance the individual places on psychological, social, health, and family associated
issues. The Ferrans and Powers QOL assessment is a valid, criterion-based instrument,
and was determined as such based on correlational values between overall satisfaction
with QOL and the instrument with dialysis patients (r = 0.7) and graduate students (r =
0.8). Test-retest correlations substantiated the reliability of the instrument (graduate
students, α = 0.9, r = 0.9; dialysis patients, α = 0.9, r = 0.9). Observed total scorings that
are higher indicate an agreement between importance placed on each dimension and
individual satisfaction with that element, which can be attributed to an overall condition
of well-being (Ferrans & Powers, 1985).
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Exercise Intervention
Prior to beginning the study, participants who were assigned to an aerobic activity
group were seated and leg-to-pedal distance was measured to allow individual flexion
and extension comfort while cycling in the recumbent position. Seat position was
recorded on data collection sheets for the purpose of consistency during the following
training sessions. Resting heart rate was recorded to evaluate % of heart rate reserve
(HRR, Karvonen Method) intensity each aerobic training group participant exercised at
during each training session. Aerobic training sessions were progressive and began at
55% HRR for weeks one-four, 60% HRR for weeks five-eight, and 65% HRR for weeks
nine-12, as detailed in Table 4. Before each warm-up session, participants were initially
required to attach a telemetric heart rate monitoring device (Polar®). However, during the
Spring of 2012 when three similar studies were being conducted and multiple clients
were being scheduled back-to-back, having participants wear heart rate monitors became
a substantial disadvantage to collecting data on time within a tight schedule (for both the
data collectors and the clients), and therefore necessitated the reliance on pulse oximetery
and heart rate monitoring via handles of the Brain Bike® apparatuses. For example, under
the assumption that the client arrived for training on time (rarely occurred), it often took
upwards of ten extra minutes to have clients grab the heart rate monitor, walk to the
bathroom, attach the monitor, stop to use the restroom, walk out of the restroom, and then
(finally) sit down to begin warming up. If the participant did not have any problems
adjusting the strap on the heart rate monitor and it was reading appropriately then training
could start only slightly behind schedule. However, many times the participants had
difficulty in putting their heart rate monitors on and an extra few minutes would have to
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be spent in order to make proper adjustments and ensure that it was reading
appropriately. In addition, because of the amount of participants training was chaotic
between three studies, many times, participants left without removing their heart rate
monitors which negatively affected the amount of heart rate monitors for clients of the
RMCRI not participating in a study. When training began, participants were asked to seat
themselves and commence their warm-up consisting of five minutes of low intensity,
self-paced cycling. Following completion of warm-up, each participant had resistance
applied to the Motion Fitness Brain Bike® recumbent cycle ergometer in order to
stimulate elevations in heart rate to the training range associated with % of HRR and
weekly progression for the duration of 30 minutes in addition to 30 minutes of flexibility
training. Those who were in the CAN-AER-COG group cycled and completed cognitive
training at the same time. In the event that the client was unable to maintain the
prescribed percentages of HRR, RPE was utilized to maintain voluntary levels of exertion
that were numerically (1-10 scale) equivalent to HRR intensities. The first Brain Bike®
recumbent cycle ergometer we obtained was generously donated by Brain Center
International (BCI) located in Quebec City, Canada. Upon completion of cognitive
training, data were wirelessly transmitted to BCI databases for analysis.
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Table 4
Aerobic training schedule and cognitive training exercises
Week
% HRR
Session

Training Exercises

1

.55

1-3

1 - 5, 1 - 5, 1 - 5

2

.55

4-6

1 - 5, 1 - 5, 6 (step
10)

3

.55

7-9

6 (step 9 - 7)

4

.55

10 - 12

6 (step 6 - 4)

5

.60

13 - 15

6 (step 3 - 1)

6

.60

16 - 18

1 - 5, 1 - 5, 1 - 5

7

.60

19 - 21

1 - 5, 1 - 5, 7 (step
10)

8

.60

22 - 24

7 (step 9 - 7)

9

.65

25 - 27

7 (step 6 - 4)

10

.65

28 - 30

7 (step 3 - 1)

11

.65

31 - 33

1 - 5, 1 - 5, 1 - 5

12

.65

34 - 36

1 - 5, 1 - 5, 1 - 5

Stretching Protocol
In order to differentiate between interventions, a total-body stretching protocol
was implemented as the control for this study. The stretching session consisted of 30
minutes of static stretches designed to target major muscle regions throughout the body.
The regions included: neck, shoulders/chest, posterior upper arm, upper back, lower back,
hips, torso, anterior thigh and hip flexor, posterior thigh, groin, and calf (Baechle &
Earle, 2008).
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Table 5
Regional bodily areas covered with stretching
Body Region
Stretching Motion

Muscles Actuated

Time
(min)
1
1

Neck

Look Right/ Left
Flexion/ Extension

-Sternocleidomastoid (SC)
-SC, Suboccipitals, Spenae

Shoulders/ Chest

Straight Arms
Behind Back
Seated Lean-Back

-Anterior Deltoid, Pectoralis
Major
- Deltoids, Pectoralis Major

1
1

Posterior Upper
Arm
Upper Back

Behind-Neck
Stretch
Cross Arms In
Front of Chest
Arms Straight Up
Above Head

-Triceps Brachii, Latissimus Dorsi

2

-Posterior Deltoid, Rhomboids,
Mid Trapezius
-Latissimus Dorsi

1
1

Lower Back

Spinal Twist

-Int/Ext Oblique, Piriformis,
Erector Spinae
-Erector Spinae

2

Hips

Semi-Butterfly
Forward Lunge
Supine Knee Flex

-Iliopsoas, Rectus Femoris
-Gluteus Maximus, Hamstrings

1
1

Torso

Side Bend With
Straight Arms

-External Oblique, Lattissimus
Dorst, Serratus Anterior

1
1

Anterior Thigh
and Hip Flexor

Side Quadriceps
Stretch

-Quadriceps, Iliopsoas

4

Posterior Thigh

Sitting Toe TouchHurdler

-Hamstrings, Erector Spinae,
Gastrocnemius
- Hamstrings, Erector Spinae,
Gastrocnemius

2

Semi-Straddle

2

2

Groin

Straddle
Butterfly

-Gastrocnemius, Hamstrings,
Erector Spinae
-Hip Adductors, Sartorius

2
1

Calf

Wall Stretch

-Gastrocnemius, Soleus, Achiles
Tendon
-Gastrocnemius, Soleus, Achiles
Tendon

1

Step Stretch
TOTAL TIME

2
30min

67
Cognitive Training Protocol
The cognitive training tasks were based on the recommendations from BCI. The
tasks included exercises which emphasized training in working memory, visuo-spatial
memory, processing speed, divided attention, selective attention, vigilance, attentional
flexibility, useful field of view, verbal processing speed, cognitive control, temporal
perception, and arithmetic operations. Division of time spent during each task was predetermined by BCI. Each of the cognitive training tasks (parking, driving, smart driving,
the policeman, brain twister, the pilot, and the stock exchange) was composed of five
minutes of training. Details of each cognitive training component are included in Table 6.
For the first five sessions participants completed parking, driving, smart driving, the
policeman, and brain twister exercises. On session six, participants then completed five
sessions of the pilot consecutively until session 16. During sessions 16-20 participants
then returned to completing parking, driving, smart driving, the policeman, and brain
twister. On session 21, participants were then required to complete five sessions of the
stock exchange consecutively until session 30. Finally, during sessions 31-36,
participants were again required to complete parking, driving, smart driving, the
policeman, and brain twister. Screenshots have been provided in Appendix C.
Parking
The parking training segment consisted of a simulated “pay to park” parking lot
where cars appeared on screen as either not paid, paid in full, or had accidentally paid
double the fee. The simulated cars that had paid the full amount blinked with a single
dollar sign encircled in red. The cars that paid double appeared on the screen as having
two dollar signs encircled in red above the car. Those cars that had not paid appeared as
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not having a dollar sign appear above them. The participant has to then memorize each
car and how they presented their status of payment and click the mouse to designate that
status. For example, the cars that appeared as not having paid required one mouse click,
cars that appeared as having paid double required two mouse clicks, and cars that
appeared to have paid the correct amount did not require any mouse clicks since they
paid correctly. The five-minute segment was broken down into smaller segments that
changed once the participant validated the set of parked cars.
Car Driving
During the car diving segment of training, the participant assumed the role of
driving a car down a series of simulated intersections and was required to make decisions
based on the appearance of oncoming street signs and lighted signals. At each
intersection participants had to decide as soon as possible whether street signs that
appeared were the same or different by inputting their response on a numerical keypad by
pressing the “/” key for the designation of same street and the “*” for the designation of
different street signs. Similarly, when each new intersection appeared, participants
inputted whether the signal appeared red or green as quickly as possible on numerical
keypad by pressing “2” for red and “3” for green. Throughout this training segment
participants also needed to be aware of the sounds of honking horns from other drivers.
Upon hearing each horn honking, participants were then required to press the “+” key on
the numerical keypad as quickly as possible.
Smart Driving
Unlike the aforementioned car driving task, smart driving doesn’t give the
participant the feeling of driving throughout simulated intersections, but has the driver
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sitting in their car during heavy, non-moving traffic. On the screen there are multiple
interactive locations where objects such as kids crossing the street or the gas light on the
dashboard that appeared randomly. Other on screen interactive areas included: the
rearview mirror, a lighted street sign located at the top of the screen, and a large street
sign in the middle of the screen. This large centrally located sign was different than the
other interactive areas in that while participants were scanning the screen for the
appearance of a lit gas can, or a child running out into the street, they needed to also
observe what picture appeared and then clicked on one of two pictures that appeared
immediately following the disappearance of the first picture. For example, the picture of
a man lifting weights may have appeared on the first sign and upon disappearance, a sign
with two picture choices appeared. Since the first picture was of a man lifting weights,
the correct answer would have been for the participant to then click on the second picture
that portrayed a man lifting weights.
The Policeman
In the policeman, the participant was given the simulated experience of being a
police officer wielding a radar gun monitoring the speeds of passing vehicles. On the top
of the screen a dialogue box indicated a number from one to five. These numbers were
reflective of the difficulty of the task. Participants were then required to remember radar
speeds that corresponded to each car and compare them against cars that followed behind
them. For example, in beginning stages of training participants may have had to compare
one car’s speed to the next; however, in advanced stages, participants could potentially
have had to compare every five cars. What makes this exceptionally difficult is that the
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first car would be compared to the fifth car, the second car compared to the sixth car, the
third car compared to the eighth car, and so on.
Brain Twister
During this task, participants are shown a light blue screen with various shapes
and descriptor terms that must be compared to a central “consistent” or “inconsistent”
banner that appears in the middle of the screen. If the central banner reads “consistent”
then participants must choose shapes and descriptors that embody consistency. For
example, among other shapes and descriptor terms, a red circle may appear with the word
“red” inside it. If the banner reads “consistent,” then the correct choice would be to
choose the red circle as the only consistent choice. The task only allows for one correct
answer, so there are no options for multiple correct answers.
The Pilot
This training task allows the participant the feeling that they are behind the
cockpit of a helicopter, although there is no motion other than the “dials” portion and the
“calculator” portion. The instructions dictate that the participant is flying a helicopter and
must evaluate the dials against the calculation portion of training. The dials are composed
of a block of six dials of equal sizes and are round shaped. The dials are stacked ion
columns of two and correspond with three different times with “24 seconds”, “12
seconds”, and “8 seconds” appearing from left to right below the dials. The calculation
panel consists of a keypad very similar to that of a standard calculator. During the
training the participant is told which task to provide a greater amount of their attention to
in conjunction with the other. For example, one segment of training may ask that the
participant prioritize the dials portion of training over the calculations panel. In this case,

71
the participant must give a greater amount of their attention to the dials as opposed to the
calculations. This training segment is broken down into three parts wherein each part will
state a new training objective that the participant must prioritize. Prioritization is never
only one or the other and may state that the participant prioritize both tasks equally.
Stock Exchange
This set of cognitive training tasks gives the participant the simulated feeling of
being on the trading floor at the New York stock exchange. On the computer display,
there is a central screen which will have a stock ticker symbol (BCI) that will move from
location to location. The participant must also be aware of a vocalized numerical value as
it pertains to the trading price of the BCI stock. During the training, the participant must
prioritize either the location of the stock symbol (same or different location) or the value
(higher or lower) by pressing corresponding keys on the keypad. This training task is
composed of five levels which will alter the prioritization of tasks and speed of delivery
as the participant increases in level of difficulty.
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Table 6
Cognitive training exercises
Number

Exercise

Trained Functions

Description

1

Parking

Working Memory
Visio-Spatial Memory

Adaptation and
classic visuo-spatial
span task

2

Car Driving

Processing Speed
Divided Attention
Selective Attention
Vigilance

Two simultaneous
biconditional
discrimination (SR) tasks with a
vigilance task

3

Smart
Driving

Processing Speed
Selective Attention
Attentional Flexibility
Useful Field of View
Divided Attention
Vigilance

Derived from
ACTIVE trial; with
UFOV program

4

The
Policeman

Working Memory
Verbal Processing Speed

Standard n-back
task with adaptable
time limit

5

Brain Twister

Processing Speed
Cognitive Control
Attentional Flexibility

Stroop-like based
on cue and reponse
conflict and
attentional set-shift
paradigm

6

The Pilot

Divided Attention
Temporal Perception
Arithmetic

Dual monitoring
task

7

Stock
Exchange

Processing Speed
Divided Attention
Working Memory

Two simultaneous
n-back tasks: one
audio-verbal and the
other visuo-spatial
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Cognitive Testing
Prior to and following the 12-week exercise intervention, each participant
underwent a comprehensive cognitive assessment (Appendix D) conducted by doctoral
students from the University of Northern Colorado School of Psychological Sciences.
Table 7
Pre/post cognitive testing measures
Neuropsychological
Instrument
Construct
General cognitive
-Wechsler Memory Scale, 4th
functioning
ed. (WMS-IV) - General
Cognitive Screener
Processing speed
Working memory,
executive function,
attention

Verbal learning &
memory

Abbreviation
BCOG

-Trail-Making A

TMT-A

-Wechsler Adult Intelligence
Scale, 4th ed. (WAIS-IV) –
Letter Number Sequencing,
Coding.

LNS raw or scaled
CD raw or scaled
TMT-B

-Trail Making B
-Wechsler Memory Scale, 4th
ed. (WMS-IV) – Logical
Memory I and II
- Wechsler Memory Scale, 4th
ed. (WMS-IV) – Delayed
Recall

LMI raw of scaled
LMII raw or scaled
LMII DR raw or scaled

Verbal fluidity

- Controlled Oral Word
Association Test

COWAT-Age
COWAT-Gender
COWAT-Education

Perceptual reasoning

-Wechsler Adult Intelligence
Scale, 4th ed. (WAIS-IV) –
Block Design

BD raw or scaled
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Statistical Analyses
Data Transformation and
Imputation
Preliminary data frequency and descriptive analyses were run to visually represent
the raw data set to address possible inconsistencies or anomalous numerical occurrences.
When missing data occurred, a series mean imputation was conducted using the
Statistical Package for the Social Sciences version 21 (SPSS, Armonk, NY) which is
detailed in Appendix E. For the cognitive variables included in this study, approximately
1.3% of data were missing and replaced. For the physiological variables included in this
study, approximately 3.6% of data were missing and replaced. In light of the fact that
group sample sizes were small and unequal, this required analysis by non-parametric
methodologies. Pre-to-post differences were then performed on all variables as a data
reduction method resulting in singular data points, and were therefore considered for
analysis.
Global Analyses
An omnibus Kruskal-Wallis Test of k independent samples [ =

∑

−

] was conducted to assess group median differences between the four training
interventions (aerobic, cognitive, and flexibility) against randomized controls for
physiological, psychological, and cognitive measures (Conover, 1999). Elliot and Hynan
(2011) reported that although the Kruskal-Wallis non-parametric analysis of variance is
an equivalent substitution for a one-way Analysis of Variance (ANOVA), it is still an
omnibus or global statistical procedure. This means that when rejection of the null
hypothesis occurs (one or more groups differ significantly) that follow-up procedures

75
should be conducted to evaluate any pairwise comparisons that may be responsible for
the significant main effects observed. Data utilized in these analyses were in direct
violation of parametric one-way ANOVA assumptions and, precisely necessitated the
adoption of non-parametric equivalents. The Kruskal-Wallis test does not provide any
specific follow-up analyses; however, Elliot and Hynan (2011) reported that GraphPad
PRISM® is a readily available statistical analysis software package that has the capability
to appropriate run this analysis with post hoc testing (Conover, 1999; Elliot & Hynan,
2011). Therefore, Kruskal-Wallis analyses were employed using GraphPad PRISM®
version 4.03 (GraphPad Inc., La Jolla, CA). Post hoc analyses are described in the
adjustments and post hoc analyses section. Wilcoxon sign ranks tests and pre-to-post
percentages were also conducted to address individual group pre-to-post changes for each
dependent variable (Glass & Hopkins, 1996). Wilcoxon sign ranks tests were performed
using Statistical Package for the Social Sciences version 21 (SPSS, Armonk, NY).
Assumptions
Data were assessed for adherence to four assumptions of Kruskal-Wallis testing
(Conover, 1999). These are: independence of observation, mutual independence among
various samples, the measurement scale is at least ordinal, and either the k observation
distribution functions are identical, or else some observations may tend to yield greater
values than other observations do.
Randomization
Randomization of groups was performed using the PROC PLAN protocol for the
Statistical Analysis Software version 9.3 (SAS, Cary, NC). Given the number of
proposed subjects and the amount of treatment groups, PROC PLAN randomly assigned
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each subject to a treatment which was then utilized as a list to follow when recruiting and
training subjects. The quasi aspect of this investigation pertained to individual discretion
as to the placement of certain subjects who presented with particular health or cognitive
issues that otherwise may have excluded them from participating in the study. For
example, a particular participant presented as a stage III oligodendroma brain cancer
patient. She expressed a profound interest in participating in the study, yet was
randomized to the flexibility only group. In light of this situation, the ethical decision was
made to allow her to participate in the aerobic and cognitive training group strictly
because of her precarious position and recommendations from her physician.
Groups
As previously mentioned, participants were randomized into one of five groups as
outlined in Table 1 and Figure 1.
Factors
Cancer status and treatment groups were the factors evaluated. Factor A was
indicative of cancer status; being those who had cancer and those who did not have
cancer. Factor B was indicative of the five training groups. In light of the fact that there
are greater than three levels to Factor B, multiple comparison procedures were
implemented.
Adjustments and Post Hoc
Analyses
Although parametric post hoc analyses and adjustments such as a Bonferroni
correction during multiple comparisons are employed to decrease the familywise error
rate [FWα = 1-(1-α)c] for the purposes of reducing Type I error risk or rejecting the null
hypothesis when it may actually be true, these methods were not employed for
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nonparametric analyses conducted (Vincent, 2005). As reported previously, the KruskalWallis test does not provide specific post hoc pairwise comparisons (Conover, 1999).
However, Kruskal-Wallis analyses were conducted using GraphPad PRISM® software
(Elliot & Hynan, 2011). Although no significant (p < 0.05) main effects were observed
between groups for each independent variable, any observed main effects, would have
been followed up with a Dunn’s post hoc assessment. For all analyses, a p-value of 0.05
was considered statistically significant.
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CHAPTER IV
RESULTS
Participant Characteristics
This study comprised a total of 35 subjects which included 28 cancer survivors
and seven apparently healthy age-matched adults who had never been diagnosed with
cancer (10 males, 25 females). The percentage of adherence to this study was 76%.
Cancer diagnoses included anaplastic oligodendroma of the left frontal lobe (1), breast
(14), breast/colon (1), colon (1), Hodgkin’s lymphoma (1), lung (1), lymphoma (1),
multiple myeloma (1), non-small cell lung/brain (1), ovarian (2), ovarian/breast (1),
prostate (1), supraglottic/laryngeal (1), and throat/tongue (1). All participants completed
each of the required 36 training sessions; however, not one participant adhered to the
requirements of completing their training within 12 weeks (average time to complete 36
sessions was approximately 20 weeks). All participants completed pre and post cognitive
assessments. Assessments were conducted by cognitive assessors from the University of
Northern Colorado School of Psychological Sciences. A total of eight different assessors
worked on this project. Because of this turnover, there were some aspects of the battery
of cognitive assessments that were unintentionally overlooked or forgotten. Therefore,
series mean imputation methodologies were employed to statistically account for missing
data (Appendix E). All participants, with the exception of one, completed pre and post
physiological assessments. Specifically, this one participant who did not complete her
post physiological assessment refused to come back because she verbally stated she was
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feeling better and the demands of her work schedule was of much greater importance
than continuing with her rehabilitation.
Physiological Assessment
Independent samples Kruskal-Wallis testing revealed no significant main (p >
0.05) effects between all five groups and all measures of physiological function, therefore
nullifying the need for post hoc analyses (Figures 2 and 3). Pre-to-post Wilcoxon sign
ranks tests revealed that SANDR increased by 39% in the CAN-AER-COG group (Table
9). VO2peak and SANDR increased by 20% and 17%, respectively in the CAN-AER group
(Table 11). SANDR increased by 22% and VO2peak significantly (p < 0.05) increased
(16%) from pre-to-post in the CAN-CON group (Table 13). RHR trended toward a
significant (p = 0.09) decrease (-13%) in the NC-CON group (Table 15). There were no
significant (p > 0.05) pre-to-post changes observed in the CAN-COG group. However,
SANDR and VO2peak increased by 24% and 12%, respectively (Table 17).
Psychological Indices
There were no significant (p > 0.05) main effects observed between all five
groups and Piper fatigue (index and subcategories), Beck Depression Inventory, and
QOL. Figures 4-10 graphically depict these comparisons. Pre-to-post percentage
decreases were observed among Beck depression and all Piper fatigue subcategories
ranging from -15 to -33% for the CAN-AER-COG group, and QOL increased by 9%
(Table 9). Specifically, the CAN-AER-COG group significantly (p < 0.05) decreased
from pre-to-post in the Piper behavioral subcategory. The CAN-AER group significantly
(p < 0.05) decreased (-34%) from pre-to-post in the Piper sensory subcategory. All other
Piper fatigue subcategories and Beck depression decreases ranged from -25% to -32%,
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while QOL increased by 13% in the CAN-AER group (Table 11). There was a significant
decrease (-55%, p < 0.05) in Beck depression, and a significant (p < 0.05) increase (26%)
in QOL observed in the CAN-CON group. In addition, the CAN-CON group also
decreased in all subcategories of Piper fatigue ranging from -40% to -67%, with the Piper
cognitive/mood subcategory trending toward significance (p = 0.09) (Table 13). There
were no significant (p > 0.05) pre-to-post differences observed in the NC-CON group.
However, Beck depression scores did decrease (-42%) (Table 15). There was a
significant (p < 0.05) decrease (-59%) and a significant (p < 0.05) increase (6%) in QOL
observed in CAN-COG pre-to-post analyses. In addition, all Piper fatigue subcategories
decreased with a range from -23% to -52% with the Piper index, affective, and
cognitive/mood subcategories trending toward significance (p = 0.08) (Table 17).
Cognitive Function
There were no significant (p > 0.05) main effects observed between all 5 groups
and for each cognitive variable (Figures 11-27). There were no significant (p > 0.05)
differences observed in any measure of cognitive function in the CAN-AER-COG group.
However, the CAN-AER-COG group did decrease from pre-to-post in measures of
reaction time (-49%, TMT-A), and increase in verbal fluidity (675%, COWAT-Z-G and
280%, COWAT-Z-A) (Table 8). There were significant (p < 0.05) increases (28%-39%)
observed among all Weschler Memory Scale (WMS-IV) raw and scaled scores, with the
exception of WMS-IV-LMII cumulative percentage scores and BCOG scores in the
CAN-AER group. In addition, there were significant (p < 0.05) increases in Weschler
Adult Intelligence Scale (WAIS-IV) block design raw and scaled scores (20% and 19%,
respectively). Furthermore, the CAN-AER group significantly (p < 0.05) increased (12%)
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from pre-to-post in the WAIS letter number sequence scaled scores, and trended toward
significance (p = 0.07). Finally, the CAN-AER group increased in 2 of the 3 measures of
verbal fluidity (70%, COWAT-Z-A and 44%, COWAT-Z-ED) (Table 10). There were no
significant pre-to-post increases in measures of cognitive function observed with the
exceptions of significant (p < 0.05) increases (750%, COWAT-Z-G; 320%, COWAT-ZA; and 205%, COWAT-Z-ED) in all COWAT verbal fluidity scores (Table 12). There
were no significant (p > 0.05) pre-to-post differences observed in the NC-CON group.
However, reaction time (TMT-B) decreased (-22%) and all 3 COWAT measures
increased (420%, COWAT-Z-G; 71%, COWAT-Z-A; and 78%, COWAT-Z-ED) (Table
14). There were no significant (p > 0.05) pre-to-post differences observed for the CANCOG group. However, all WMS-IV scores increased ranging from 6%-20% with the
exception of WMS-IV cumulative percentage (CP) scores. Reaction times (TMT-B) also
decreased (-26%). All measures of verbal fluidity increased (156%, COWAT-Z-G;
574%, COWAT-Z-A; and 60%, COWAT-Z-ED) (Table 16).
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Figure 2. Group Comparisons of VO2peak. CAN, cancer; COG, cognitive training; AER,
aerobic training; CON, non-cancer controls. Data are mean ± SD.
7

Post-to-Pre Differences (in.)

6
5
4
3
2
1
0
-1
-2
-3
CAN-AER-COG

CAN-AER

CAN-CON

NC-CON

CAN-COG

Figure 3. Group Comparisons of Sit and Reach Scores. CAN, cancer; COG, cognitive
training; AER, aerobic training; CON, non-cancer controls. Data are mean ± SD.
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Figure 4.Group Comparisons of Piper Fatigue Index Overall Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 5. Group Comparisons of Piper Fatigue Index Behavioral Scores. CAN, cancer;
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are
mean ± SD.
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Figure 6. Group Comparisons of Piper Fatigue Index Affective Scores. CAN, cancer;
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are
mean ± SD.
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Figure 7. Group Comparisons of Piper Fatigue Index Sensory Scores. CAN, cancer;
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are
mean ± SD.
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Figure 8. Group Comparisons of Piper Fatigue Index Cognitive Scores. CAN, cancer;
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are
mean ± SD.
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Figure 9. Group Comparisons of Beck Depression Inventory Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 10. Group Comparisons of Ferrans and Powers Quality of Life Index Scores.
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer
controls. Data are mean ± SD.
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Figure 11. Group Comparisons of General Cognitive Screening. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 12. Group Comparisons of Logical Memory I Raw Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 13. Group Comparisons of Logical Memory I Scaled Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 14. Group Comparisons of Logical Memory II Delayed Recall Raw Scores. CAN,
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data
are mean ± SD.
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Figure 15. Group Comparisons of Logical Memory II Delayed Recall Scaled Scores.
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer
controls. Data are mean ± SD.
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Figure 16. Group Comparisons of Logical Memory II Cumulative Percentage Scores.
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer
controls. Data are mean ± SD.
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Figure 17. Group Comparisons of Trail Making Test-A Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 18. Group Comparisons of Trail Making Test-B Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 19. Group Comparisons of WAIS Block Design Raw Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 20. Group Comparisons of WAIS Block Design Scaled Scores. CAN, cancer;
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are
mean ± SD.
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Figure 21. Group Comparisons of WAIS Letter Number Sequencing Raw Scores. CAN,
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data
are mean ± SD.
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Figure 22. Group Comparisons of WAIS Letter Number Sequencing Scaled Scores.
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer
controls. Data are mean ± SD.
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Figure 23. Group Comparisons of WAIS Coding Raw Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.
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Figure 24. Group Comparisons of WAIS Coding Scaled Scores. CAN, cancer; COG,
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ±
SD.

Pre-to-Post Differences
COWAT-Gender
(z-scores)

1.0

0.5

0.0

-0.5
CAN-AER-COG

CAN-AER

CAN-CON

NC-CON

CAN-COG

Figure 25. Group Comparisons of Controlled Oral Word Association Test-Gender. CAN,
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data
are mean ± SD.
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Figure 26. Group Comparisons of Controlled Oral Word Association Test-Age. CAN,
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data
are mean ± SD.
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Figure 27. Group Comparisons of Controlled Oral Word Association Test-Education.
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer
controls. Data are mean ± SD.

Table 8
CAN-AER-COG wilcoxon sign ranks test: cognitive variables and percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
WMS_IV_BCOG
54.55
3.64
54.67
3.54
0.93
0.22
WMS_IV_LMI_RAW
26.89
7.90
25.89
4.54
0.57
-3.72
WMS_IV_LMI_SCALED
10.33
3.00
10.33
2.00
0.87
0.00
WMS_IV_LMII_DR_RAW
24.33
6.56
26.22
4.97
0.26
7.77
WMS_IV_LMII_DR_SCALED
11.44
2.74
12.22
2.17
0.27
6.82
WMS_IV_LMIICP_RAW
26.89
2.47
26.22
1.20
0.40
-2.49
TMT_A_RAW
60.44
80.02
30.67
10.00
0.14
-49.26
TMT_B_RAW
69.44
20.34
72.22
29.75
0.95
4.00
WAIS_IV_BD_RAW
32.00
12.34
35.56
12.00
0.27
11.13
WAIS_IV_BD_SCALED
9.00
2.96
9.89
2.89
0.26
9.89
WAIS_IV_LNS_RAW
20.67
3.16
20.56
2.79
0.89
-0.53
WAIS_IV_LNS_SCALED
11.56
3.43
11.44
2.88
1.00
-1.04
WAIS_IV_CD_RAW
68.78
19.57
68.33
24.00
0.87
-0.65
WAIS_IV_CD_SCALED
11.78
3.87
11.78
4.06
1.00
0.00
COWAT_Z_G
-0.04
1.60
0.23
1.80
0.31
675.00
COWAT_Z_A
0.10
1.57
0.38
1.78
0.26
280.00
COWAT_Z_ED
-0.20
1.52
-0.17
1.75
0.86
15.00
th
Note: WMS IV, Weschler Memory Scale (4 Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score;
G, gender; A, age; ED, education).
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Table 9
CAN-AER-COG wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
SBP
122.67
13.56
120.22
10.89
0.40
-2.00
DBP
74.78
6.00
72.56
7.92
0.41
-2.97
RHR
73.78
10.45
70.89
12.33
0.31
-3.92
VO2PEAK
21.07
8.35
21.62
8.48
0.95
2.61
SANDR
9.58
2.28
13.28
8.52
0.31
38.62
PIPER_I
4.60
1.39
3.52
2.35
0.07
-23.48
PIPER_B
3.81
2.71
2.57
2.48
*0.01
-32.55
PIPER_A
5.02
2.06
3.93
3.25
0.25
-21.71
PIPER_S
5.18
1.06
4.38
2.22
0.24
-15.44
PIPER_C
4.78
0.73
3.48
2.16
0.07
-27.20
BECK
9.78
4.76
7.44
6.15
0.10
-23.93
QOL
20.87
2.01
22.79
6.00
0.09
9.20
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S,
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p <
0.05).

96

94

Table 10
CAN-AER wilcoxon sign ranks test: cognitive variables and percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
WMS_IV_BCOG
54.00
5.26
52.71
4.54
0.61
-2.39
WMS_IV_LMI_RAW
19.00
4.16
24.29
5.25
*0.03
27.84
WMS_IV_LMI_SCALED
7.00
1.73
9.29
2.29
*0.03
32.71
WMS_IV_LMII_DR_RAW
15.57
6.43
21.71
5.09
*0.04
39.43
WMS_IV_LMII_DR_SCALED
7.86
3.13
10.00
2.31
*0.05
27.23
WMS_IV_LMIICP_RAW
24.00
2.94
24.29
3.15
0.79
1.21
TMT_A_RAW
36.86
7.60
36.43
14.19
0.75
-1.17
TMT_B_RAW
87.29
9.79
98.14
34.19
0.50
12.43
WAIS_IV_BD_RAW
33.57
8.60
40.43
7.13
*0.03
20.43
WAIS_IV_BD_SCALED
9.00
1.83
10.71
1.11
*0.03
19.00
WAIS_IV_LNS_RAW
16.86
1.07
18.14
1.35
0.07
7.59
WAIS_IV_LNS_SCALED
8.14
0.69
9.14
0.90
*0.04
12.29
WAIS_IV_CD_RAW
51.14
17.23
57.43
8.52
0.35
12.30
WAIS_IV_CD_SCALED
9.14
1.46
10.28
1.38
0.20
12.47
COWAT_Z_G
-0.54
0.31
-0.63
1.10
0.74
-16.67
COWAT_Z_A
-0.46
0.37
-0.14
0.61
0.13
69.57
COWAT_Z_ED
-0.80
0.56
-0.45
0.81
0.13
43.75
th
Note: WMS IV, Weschler Memory Scale (4 Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score;
G, gender; A, age; ED, education. * denotes results were significant (p < 0.05).
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Table 11
CAN-AER wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
129.14
21.87
128.77
23.4
0.46
-0.29
SBP
78.71
8.18
78.8
14.05
1.00
0.11
DBP
76.86
8.45
69.69
11
0.24
-9.33
RHR
18.67
5.43
22.4
8
0.09
19.98
VO2PEAK
10.64
4.44
12.48
2.83
0.25
17.29
SANDR
4.62
3.61
3.39
3.26
0.18
-26.62
PIPER_I
5.39
3.7
3.69
3.53
0.08
-31.54
PIPER_B
5.66
4.21
4.1
2.83
0.09
-27.56
PIPER_A
5.26
2.78
3.49
2.54
*0.04
-33.65
PIPER_S
5.02
2.83
3.74
2.68
0.06
-25.5
PIPER_C
10.86
7.86
7.8
7
0.18
-28.18
BECK
19.45
6.68
22.04
4.12
0.12
13.32
QOL
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S,
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p <
0.05).
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Table 12
CAN-CON wilcoxon sign ranks test: cognitive variables and percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
54.29
3.20
55.71
4.27
0.28
2.62
WMS_IV_BCOG
25.14
6.79
27.43
6.13
0.24
9.11
WMS_IV_LMI_RAW
9.43
2.88
10.71
2.21
0.14
13.57
WMS_IV_LMI_SCALED
20.43
7.81
23.86
6.54
0.13
16.79
WMS_IV_LMII_DR_RAW
12.14
5.27
11.29
2.36
0.83
-7.00
WMS_IV_LMII_DR_SCALED
25.14
3.48
24.87
3.63
0.93
-1.07
WMS_IV_LMIICP_RAW
29.43
7.96
30.00
11.11
0.93
1.94
TMT_A_RAW
74.71
22.51
72.43
46.84
0.50
-3.05
TMT_B_RAW
37.14
9.60
40.71
8.14
0.60
9.61
WAIS_IV_BD_RAW
10.43
2.51
11.00
1.91
0.91
5.47
WAIS_IV_BD_SCALED
20.38
1.83
20.10
2.04
0.92
-1.37
WAIS_IV_LNS_RAW
10.60
2.21
10.76
2.86
0.67
1.51
WAIS_IV_LNS_SCALED
65.00
5.42
66.71
17.34
0.40
2.63
WAIS_IV_CD_RAW
10.71
1.63
11.43
3.31
0.29
6.72
WAIS_IV_CD_SCALED
0.06
0.83
0.51
0.84
*0.04
750.00
COWAT_Z_G
0.15
0.86
0.63
0.85
*0.03
320.00
COWAT_Z_A
-0.22
0.91
0.23
1.00
*0.05
204.55
COWAT_Z_ED
th
Note: WMS IV, Weschler Memory Scale (4 Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score;
G, gender; A, age; ED, education. * denotes results were significant (p < 0.05).
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Table 13
CAN-CON wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
SBP
123.00
9.71
121.14
7.36
0.74
-1.51
DBP
74.00
7.67
77.14
7.19
0.35
4.24
RHR
92.71
10.56
100.29
17.26
0.24
8.18
VO2PEAK
16.93
8.25
19.59
7.59
*0.05
15.71
SANDR
13.19
2.49
16.15
7.37
0.24
22.44
PIPER_I
2.43
2.51
1.42
1.44
0.40
-41.56
PIPER_B
3.20
3.28
1.05
1.11
0.12
-67.19
PIPER_A
2.74
2.83
1.64
1.48
0.35
-40.15
PIPER_S
3.63
3.01
1.86
1.58
0.13
-48.76
PIPER_C
2.92
2.81
1.39
1.76
0.09
-52.40
BECK
9.29
7.43
4.20
3.20
*0.04
-54.79
QOL
19.76
4.80
24.91
3.13
*0.02
26.06
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S,
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p <
0.05).
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Table 14
NC-CON wilcoxon sign ranks test: cognitive variables and percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
WMS_IV_BCOG
56.66
1.46
56.86
1.46
0.50
0.35
WMS_IV_LMI_RAW
24.71
3.73
26.00
3.92
0.34
5.22
WMS_IV_LMI_SCALED
10.00
1.83
10.43
1.81
0.33
4.30
WMS_IV_LMII_DR_RAW
20.57
3.87
22.86
4.98
0.10
11.13
WMS_IV_LMII_DR_SCALED
9.42
1.40
10.57
1.99
0.07
12.21
WMS_IV_LMIICP_RAW
25.73
1.76
25.57
2.44
0.69
-0.62
TMT_A_RAW
37.57
12.50
33.86
7.43
0.35
-9.87
TMT_B_RAW
66.14
16.15
51.86
6.62
0.06
-21.59
WAIS_IV_BD_RAW
40.86
14.60
43.86
14.72
0.40
7.34
WAIS_IV_BD_SCALED
10.71
4.11
11.43
3.31
0.52
6.72
WAIS_IV_LNS_RAW
20.14
1.95
20.00
1.41
0.83
-0.70
WAIS_IV_LNS_SCALED
10.57
1.99
10.14
0.69
0.52
-4.07
WAIS_IV_CD_RAW
74.00
9.38
69.71
15.68
0.89
-5.80
WAIS_IV_CD_SCALED
11.57
1.81
11.43
2.07
0.72
-1.21
COWAT_Z_G
0.05
0.67
0.26
0.48
0.35
420.00
COWAT_Z_A
0.17
0.62
0.29
0.49
0.53
70.59
COWAT_Z_ED
-1.30
2.71
-0.29
0.53
0.35
77.69
th
Note: WMS IV, Weschler Memory Scale (4 Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score;
G, gender; A, age; ED, education).* denotes results were significant (p < 0.05).
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Table 15
NC-CON wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
SBP
127.86
14.31
127.34
10.25
0.55
-0.41
DBP
77.71
12.35
76.80
12.91
0.93
-1.17
RHR
88.14
14.72
77.12
12.95
0.09
-12.50
VO2PEAK
31.25
8.83
28.96
6.47
0.17
-7.33
SANDR
11.67
3.68
10.68
3.89
0.61
-8.48
PIPER_I
2.58
1.80
2.37
1.94
0.87
-8.14
PIPER_B
1.24
1.26
1.42
2.64
0.72
14.52
PIPER_A
2.69
2.84
2.51
2.29
0.92
-6.69
PIPER_S
3.54
2.49
3.66
2.37
0.87
3.39
PIPER_C
2.63
2.34
2.38
1.84
0.83
-9.61
BECK
5.40
2.72
3.14
5.37
0.18
-41.85
QOL
24.18
3.77
24.84
3.46
0.50
2.73
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S,
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p <
0.05).
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Table 16
CAN-COG wilcoxon sign ranks test: cognitive variables and percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
WMS_IV_BCOG
53.20
5.31
56.60
1.67
0.13
6.39
WMS_IV_LMI_RAW
21.60
7.92
24.40
3.91
0.41
12.96
WMS_IV_LMI_SCALED
8.00
3.39
9.60
1.67
0.13
20.00
WMS_IV_LMII_DR_RAW
18.40
8.56
21.80
6.72
0.08
18.48
WMS_IV_LMII_DR_SCALED
9.20
3.70
10.20
2.95
0.16
10.87
WMS_IV_LMIICP_RAW
24.40
2.30
24.00
2.35
0.58
-1.64
TMT_A_RAW
29.20
10.99
31.69
9.92
0.47
8.53
TMT_B_RAW
92.60
33.65
68.98
20.50
0.14
-25.51
WAIS_IV_BD_RAW
27.40
5.98
31.40
3.97
0.23
14.60
WAIS_IV_BD_SCALED
7.80
1.64
9.00
1.41
0.10
15.38
WAIS_IV_LNS_RAW
20.00
1.22
19.20
1.10
0.10
-4.00
WAIS_IV_LNS_SCALED
9.60
0.89
9.60
0.55
1.00
0.00
WAIS_IV_CD_RAW
66.20
10.40
69.80
8.29
0.14
5.44
WAIS_IV_CD_SCALED
12.00
1.58
11.80
1.92
0.71
-1.67
COWAT_Z_G
-0.14
0.78
0.08
0.66
0.35
155.56
COWAT_Z_A
-0.04
0.75
0.18
0.67
0.28
573.68
COWAT_Z_ED
-0.62
0.63
-0.25
0.60
0.23
59.68
th
Note: WMS IV, Weschler Memory Scale (4 Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score;
G, gender; A, age; ED, education).
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Table 17
CAN-COG wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes
Variable
Pre Mean
Pre SD
Post Mean
Post SD
SIG.
% Change
SBP
99.60
47.14
126.28
11.35
0.23
26.79
DBP
79.20
13.75
72.93
8.45
0.27
-7.92
RHR
84.60
15.11
85.37
14.43
0.69
0.91
VO2PEAK
20.08
4.88
22.50
5.21
0.35
12.05
SANDR
11.62
5.01
14.39
2.88
0.23
23.84
PIPER_I
6.07
2.68
2.91
1.44
0.08
-52.06
PIPER_B
3.41
2.06
1.73
1.70
0.23
-49.27
PIPER_A
4.00
1.98
3.08
1.67
0.08
-23.00
PIPER_S
5.80
1.33
3.60
2.31
0.14
-37.93
PIPER_C
4.73
0.56
3.23
1.30
0.08
-31.71
BECK
8.20
1.79
3.40
1.52
*0.04
-58.54
QOL
22.12
1.47
23.54
1.47
*0.04
6.42
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S,
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p <
0.05).
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CHAPTER V
DISCUSSION
Cancer is a multifaceted phenomenon that negatively affects millions of people
worldwide (Jemal et al., 2011). It requires the development of scientifically-based tactics
that are of holistic and multi-faceted in nature for not only the treatment of the disease,
but for the rehabilitation process. Current progressive methods of prevention, detection,
education, and treatment, along with increased implementation of individualized cancer
rehabilitation programs have played a substantial role in the current estimates of
increased survival rates (ACS, 2014). However, incidences of cancer continue to increase
therefore, unequivocally, calls for continued research that aims to holistically address the
specific, multifaceted, needs of this growing population.
Chemotherapy-related cognitive impairment has gained traction in the lay and
scientific literature as being an ever increasing, disruptive, and frustrating phenomenon
which negatively affects cancer survivors undergoing treatment. This project addressed
factors that may play a role in the reduction or attenuation of CRCI, a side effect of
treatment that has been reported to negatively affect the lives of upwards of 75% of those
who have undergone treatment (Jackson, 2008; Myers, 2009; Konat et al., 2008; & Raffa
& Tallarida, 2010). The purpose of this study was to examine the effects of a quasirandomized, controlled 12-week aerobic and cognitive intervention on cancer survivors
(CAN) versus non-cancer participants (NC).
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It was hypothesized that aerobic cycling on a recumbent cycle ergometer would
increase measures of cognitive function in CAN. Second, cognitive training using
computer software consisting of brain training exercises was hypothesized to increase
measures of cognitive function in CAN. Finally, it was hypothesized that the combined
cognitive and aerobic training would have a synergistic effect on increases in cognitive
function in CAN. Despite global analyses revealing no significant (p > 0.05) differences
between each of the groups for physiological, psychosocial, or cognitive measures, the
within group results suggest that aspects of these types of modalities may be effective at
targeting CRCI. Although the methodology needs refinement to better focus the efforts
on CRCI, the results of this investigation has provided fertile groundwork for research
investigations in the future. For example, at home cognitive training using commercially
available programs such as Posit-Science® and Lumosity® may actually remove the
combined difficulty and cognitive demand observed in the groups that had the combined
cognitive and aerobic training, thereby allowing participants better focus on aerobic
training.
Aerobic, Cognitive, and Flexibility Training
(CAN-AER-COG)
Although the hypothesis that the combined CAN-AER-COG group would
generate the greatest overall increases in measures of aerobic and cognitive function, this
group produced the least amount of improvements compared to any other group from
pre-to-post. Yet, there were still aspects of this treatment group that deserve mention.
Increases in TMT-A speed suggest that training may have an impact on their ability to
reproduce the task with greater speed and efficiency. The TMT-A test has been reported
to be utilized in multiple population samples as a test of mental processing speed and
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executive function (Park & Larson, 2015). Processing speed has been roughly defined as
being the speed of completing a task with a relative or reasonable accuracy (Jacobson et
al., 2011). In addition, Lezak, Howieson, Bigler, and Tranel (2012) defined executive
function as individual capacitance to engage successfully in self-directed, purposive,
independent, and self-serving behavior. Part “A” of the Trail Making Test A and B is
focused on the former being the processing speed. In this case, the CAN-AER-COG
group increased in their speed of processing by 49% (pre 60.4 ± 80.0 vs. post 30.7 ± 10
seconds, p = 0.14) from pre-to-post. Although insignificant, a 49% increase in processing
speed among cancer survivors may be a factor in the gaining of confidence in abilities or
capabilities that had been reduced or abandoned while undergoing treatment. For
example, a particular client in this group was told she absolutely should not drive her
vehicle, (A) because of the high dosages of chemotherapy and radiation she was
undergoing, and (B) because of how unwell she felt on a daily basis. Following the
completion of chemotherapy and radiation treatment and at the discretion of her
physician, she was then allowed to drive. This increase of 49% increase in the ability of
the brain to process signals may appear as statistically insignificant, but to a cancer
survivor, who is beginning to drive again after three months of not driving, a 49%
increase in processing speed may be quite important.
Controlled Oral Word Association Test gender and age scores also improved by
675% and 275%, respectively (pre -0.04 ± 1.6 vs. post 0.2 ± 1.8; pre 10 ± 1.6 vs. post 0.4
± 1.8) for the CAN-AER-COG group, suggesting that improvements were made for word
association following training. Foster et al. (2013) noted that the COWAT test requires
participants to come up with as many words as they possibly can within the given time
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limit for a specified letter. These particular assessments make an adjustment for gender
and age. However, regardless of the insignificance, it is important to note that the sheer
number of word associations (or verbal fluidity) increased following the intervention.
Fatigue significantly decreased in the CAN-AER-COG group (-33%) (pre 3.8 ±
2.7 vs. post 2.6 ± 2.5, p < 0.05) in the Piper Fatigue Index Behavioral subcategory and
there was a trend toward significant decreases (-24%) (pre 4.6 ± 1.4 vs. post 3.5 ± 2.4, p
= 0.07) in the overall Piper Fatigue Index score. There was a trend toward a significant
decrease (-27%) (pre 4.8 ± .7 vs. 3.5 ± 2.2, p = 0.07) in the Cognitive subcategory, and
there were decreases (-22%, -15%, -24%) in the Piper Fatigue Index Affective and
Sensory subcategories. This is still a matter of importance for the cancer survivor.
Fatigue has been reported to manifest itself much differently in cancer survivors than
apparently healthy adults. Finsterrer and Mahjoub (2014) described CRF as being
overwhelming resting tiredness that may inhibit activities of daily living, decrease vigor
and endurance, and may persist for long periods of time, ultimately affecting QOL in a
negative manner. In addition, CRF may also negatively impact psychosocial aspects of
function such as those measured in this study, consequently acting as a disabling factor to
the individual’s life (Finsterer & Mahjoub, 2014). It is important to note that depression
and fatigue are all factors that play a substantial role in not only activities of daily life,
but more importantly, overall QOL.
Quality of Life only improved by 9% in the CAN-AER-COG group suggesting
that this type of training may not be the preferred method of intervention for cancer
survivors going through treatment. Anecdotal information received from multiple clients
helped to substantiate this. Many clients would state that they would have to reduce their
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pedal rate in order to focus on the extremely difficult games, suggesting a neurological
conflict of sorts may have been occurring such that the ability of the brain to appropriate
the amount of processing capability between two difficult tasks. In addition, there were
many times where clients had actually broken down in tears because they were so
incredibly frustrated with the difficulty of not only their current treatment regimens, but
how hard it was for them to concentrate with CRCI. Among the non-pharmacological
approaches to addressing CRCI, these results suggest that combined training may not be
the most appropriate for this particular population.
Aerobic and Flexibility Training
(CAN-AER)
Recently it was reported that among apparently healthy males that exercise of a
moderate intensity (65% HRR) for 20 minutes significantly (p < 0.05) increased accuracy
and speed as a measure of cognitive performance (Stroop test) when compared to ten or
45 minutes of cycling, suggesting a dose-response relationship between aerobic exercise
and cognitive function (Chang et al., 2015). Although the aforementioned comparison is
a much different group, it is important to state that among all treatment groups, those that
were randomized to the CAN-AER group were by far the most significantly improved
group among pre-to-post measures of cognitive function. Measures of WMS-LMI raw
and scaled scores significantly (pre 19.0 ± 4.2 vs. post 24.3 ± 5.3, p < 0.05; pre 7.0 ± 1.7
vs. post 9.3 ± 2.3, p < 0.05) increased (28%, 33%, respectively). WMS-LMII DR raw and
scaled scores significantly (pre 15.6 ± 6.4 vs. post 21.7 ± 5.1, p < 0.05; pre 7.9 ± 3.1 vs.
post 10.0 ± 2.3, p < 0.05) increased (39%, 27%, respectively). The WMS-LMI has been
reported by the British Psychological Society (2012) to be a measure of narrative
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working memory, while the WMS-LMII-DR has been reported to be a measure of
narrative delayed recall, or longer term memory (BPS, 2012).
Various structures in the brain are associated with memory; of particular
importance to this investigation, in the hippocampus. A particular study evaluating the
effects of seven weeks of aerobic training (50-75% HRR) on brain volumetric changes in
apparently healthy older adults revealed significant increases in hippocampal volumes
and increases in cognitive tests of memory (Erickson et al., 2011). Results from the
current investigation corroborate those observations: (A) aerobic training does increase
aspects of memory, but for cancer survivors undergoing treatment, it may necessitate
reductions in training percentages of HRR to account for the added physical and
cognitive demand of chemotherapy treatment, and (B) increases of memory observed
within the CAN-AER group during this study may have been due to volumetric increases
in the hippocampus.
Weschler Adult Intelligence Scale Block Design raw and scaled scores both
significantly increased (pre 33.5 ± 8.6 vs. post 40.4 ± 7.1, p < 0.05; pre 9.0 ± 1.8 vs. post
10.7 ± 1.1, p < 0.05) by 20% and 19%, respectively. The WAIS block design test has
been reported to be a visual test of perceptual reasoning and visual processing (Benson,
Hulac, & Kranzler, 2010; Ward, Bergman, & Hebert, 2012). Cognitive assessors show
participants various shapes that the participant is encouraged to reproduce using their
own set of multi-colored blocks. These results suggest that perceptions and processing of
the visual components increased potentially as a result of aerobic exercise. WAIS LNS
scaled scores significantly (pre 8.1 ± .7 vs. post 9.1 ± .9, p < 0.05) increased (12%).
WAIS CD raw and scaled scores were statistically insignificant (p > 0.05) yet increased
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by 12% and 13%, respectively. Both the LNS and CD tests are visual assessments of
executive function and working memory (Benson et al., 2010; Ward et al., 2012) again
suggesting that aerobic exercise corroborates with findings of previous studies.
Finally, measures of COWAT age and education scores, although statistically
insignificant (p > 0.05) increased by 70% and 44%, respectively. Whether this was a
function of the intervention itself or a recovery of previously attained levels of verbal
fluidity, is yet to be determined. Yet, COWAT gender scores decreased by 17%,
suggesting that there may have been a different response between males and females in
verbal fluidity. Formulating a judgment on this particular result is difficult because (A)
this group was disproportionately composed of females (n = 5) vs. males (n = 2), and (B)
one of the female participants in this group had stage III brain cancer and had significant
difficulties with verbal tasks due to the removal of large portions of her temporal lobe.
This circumstance may have potentially affected the results which suggested that this
group decreased in measures of verbal fluidity. For example, words that began with “s”
were particularly difficult to say.
Chang et al. (2015) suggested that cognitive improvements as a function of
moderate intensity (65% HRR) aerobic exercise may in fact follow the inverted U
paradigm such that an optimal intensity and time may be necessary to yield the greatest
amount of intervention-related cognitive changes, at least in apparently healthy males.
When data collection commenced for the current study, some of the first participants had
been out of treatment for a few weeks and the appropriate HRR values for each
corresponding segment of training were accomplished. However, following a shift in
oncologist referring, most participants from that point forward were still undergoing
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treatment. During this study, 30 minutes of aerobic cycling was attempted at 55%, 60%,
and 65% (HRR), however, maintaining each exact HRR was often times difficult to
accomplish during many training sessions throughout data collection because subject
functional capacity often changed from day-to-day with treatment. For example, a
particular participant who was undergoing chemotherapy and radiation would often
complete training at the required intensities, but on the one day per week that followed
her chemotherapy infusions, she often could only complete a few minutes at the
prescribed intensity due to overwhelming fatigue. This aspect of training transcended all
of the CAN groups with the exception of the CAN-CON group and necessitated the
implementation of the RPE scale to better equalize the training and allow participants to
complete the session.
In light of the prevalence of this issue among those in groups that trained
aerobically (who were undergoing treatment), it should be noted that intensities proposed
in this study could not be strictly adhered to. In addition, intensities proposed in this
study may have very well been appropriate for those who had completed treatment weeks
prior, but not for those undergoing treatment. Furthermore, even though the results do
suggest that this model of aerobic training produced significant increases in measures of
cognitive function in this sample, a more appropriate level of intensity, perhaps between
40% and 55% HRR may more appropriately reflect the specific needs of the population.
Piper sensory subscale significantly (pre 5.3 ± 2.8 vs. post 3.5 ± 2.5, p < 0.05)
decreased (34%). The Piper cognitive subscale trended toward significance (pre 5.0 ± 2.8
vs. post 3.7 ± 2.7, p < 0.05) and decreased by 26%. Piper behavioral and affective scores
both trended toward significant decreases (pre 5.4 ± 3.7 vs. post 3.7 ± 5.5, p = 0.08; pre
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5.7 ± 4.2 vs. post 4.1 ± 2.8, p = 0.09) (-32% and -28%, respectively). Piper index scores
and Beck depression also decreased -27% and -28%, respectively. VO2peak, sit and reach,
and QOL scores, although statistically insignificant, increased by 20%, 17%, and13%
from pre-to-post. Overall increases in measures of cognitive function, VO2peak, sit and
reach, decreases in fatigue, depression, and increases in QOL all suggest that the
combination of aerobic and flexibility training should be further examined to better
understand how best to implement this type of training in cancer survivors.
Flexibility Training (CAN-CON)
Multiple studies have indicated the impact of various types of flexibility training
on cancer survivors. For example, in a review of literature composed of 25 studies
evaluating the effects of yoga as a component of cancer interventions, Culos-Reed et al.
(2012) found that among various interventions that implemented yoga that this type of
training may be quite effective as a rehabilitative modality for cancer survivors.
Furthermore, Culos-Reed et al. (2012) noted that yoga was associated with increases in
QOL and spiritual well-being, decreases in anxiety, depression, and fatigue. Although,
the CAN-CON group did not participate in yoga, the participants did complete 36
sessions of whole-body static stretching. Results from this study do, somewhat,
corroborate findings from studies that evaluated the effects of yoga. VO2peak trended
toward significant increases (pre 16.9 ± 8.3 vs. post 19.6 ± 7.6, p = 0.05; 16%). Quality
of life significantly increased (pre 19.8 ± 4.8 vs. post 24.9 ± 3.1, p < 0.05) (26%) for the
CAN-CON group. The Piper behavior and cognitive subscales decreased (pre 3.2 ± 3.3
vs. post 1.1 ± 1.1, -67%; pre 2.9 ± 2.8 vs. post 1.4 ± 1.7, -52%). Beck depression
significantly decreased (pre 9.3 ± 7.4 vs. post 4.2 ± 3.2, p < 0.05) (-55%).
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Finally, Piper index, affective, and sensory subscales all decreased (-41.6, -40.5,
and -48.8, respectively), and sit and reach increased by 22% in the CAN-CON group.
These pre-to-post changes reflect an important component of cancer rehabilitation that
may have been overlooked or underrated, which may actually be a substantial tool in the
arsenal of cancer exercise specialists who are training clients that are currently
undergoing treatment and may not be able to fully tolerate exercise. This area of cancer
rehabilitation lacks a significant amount of research regarding physiological changes that
may explain the results obtained during this study. However, other studies have
implemented the Chinese therapeutic method of Qi-gong, which is not technically
flexibility training or yoga. However, Qi-gong may be a much closer modality for
comparison considering the subtlety of movements are slow-paced, require a modicum of
active muscle stretch during each movement, and aid in breathing techniques which are
mildly similar to static stretching (Yeh, Lee, Chen, & Chao, 2006; Lee, Loh, & Murray,
2011). Of the few studies that have evaluated physiological alterations following Qi-gong
interventions in cancer patients undergoing treatment, Yeh et al. (2006) reported the
effects of Qi-gong on multiple blood parameters. The investigators concluded that
following the intervention white blood cell count and platelet count significantly
increased among those undergoing treatment for cancer. Although no definitive
explanation can be given for the results obtained from the current study, it bears
importance that future investigations include delving into potential mechanistic actions
that may better elucidate the benefits of flexibility training on functional capacity and
CRCI in cancer survivors.
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Little research exists that has evaluated the effects of a static-stretching, yoga, or
Qi-gong on measures of cognitive function. In addition, those reviewed had cognitive
assessment batteries that were completely different from what was conducted in this
study. Furthermore, there was even less research that evaluated the aforementioned in a
cancer survivor population. However, in an investigation of the effects of a six-month
yoga-based intervention on measures of cognitive function among apparently healthy
adults over 60 years of age, Hariprasad et al. (2013) found that following the
intervention, significant increases were observed among delayed recall of visual and
verbal memory, executive function, working memory and attention, processing speed,
and verbal fluency. In this study no other measure of cognitive function significantly
increased for the CAN-CON group except the COWAT gender (pre .06 ± .8 vs. post .5 ±
.84, p < 0.05), age (pre .15 ± .9 vs. post .6 ± .85, p < 0.05), and education scores (pre -.2
± .9 vs. post .2 ± 1.0, p < 0.05), which partially substantiates the results presented in the
Harisprasad et al. (2013) study suggesting that verbal fluency significantly increased
following the intervention.
Although not entirely understood, the main differences between the studies may
have been responsible for the outcomes that were observed. These were: (A) apparently
healthy older adults, (B) the intervention consisted of yoga as opposed to static
stretching, and (C) the duration of the yoga intervention was six months as opposed to
three in this study. It may very well be that because a vast majority of the participants in
this study were undergoing chemotherapy and/or radiation treatment, that the targeted
flexibility protocol was ineffective in the reduction of CRCI. However, measures of
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verbal fluency significantly improved in this group from pre-to-post suggesting that a
factor of training played a role in these observed improvements.
Due to the nature of the flexibility protocol being very socially interactive, the
one-on-one personal training administered during training may have played a role in
increased verbal fluency. In addition, it would be near impossible to have implemented
this type of training intervention without a modicum of social interaction or facilitation of
the individual stretches, and regularly attending clients of RCMRI often report how they
enjoy the time they get to spend interacting with their trainers. This suggests that
participants are positively affected by this type of training which may explain the
increases in measures of word association.
Aerobic, Cognitive, and Flexibility Training (NC)
The apparently healthy control group appeared to increase the least when
compared to pre-to-post changes among the CAN groups. This may be due to the fact that
many of the age-matched, apparently healthy adults who were included in this study were
actually more actively engaged in daily living activities of both physical and cognitive
demand than they perceived. However, some aspects of cognitive function did increase
following the completion of the study. WMS-LMII DR scaled scores trended toward
significant increases (pre 9.4 ± 1.4 vs. post 10.6 ± 2.0, p = .07) (12%) which would
indicate that aspects of long-term memory increased as a result of the training, which
although beneficial, these results are not impactful enough to conclude that the cognitive
training was responsible for outcomes observed. In addition, TMT-B scores trended
toward significant decreases (pre 66.1 ± 12.2 vs. post 51.9 ± 6.6, p = 0.06) in speed of
processing for TMT-B (-22%). All COWAT gender, age, and education scores increased
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(420%, 71%, and 78%, respectively). No pre-to-post changes in physiological or
psychosocial variables produced significant changes following the completion of the
study. However, RHR trended toward a significant decrease (pre 88.14 ± 14.7 vs. post
77.12 ± 13.0, p = 0.09) (-13%). Finally, Beck depression decreased by (-42%). This could
be explained in part because of the married couple who participated together in the study.
The husband was a Greeley police officer who was part of a cyber team that investigated
computer equipment of individuals that were suspects in cases where there were crimes
against children. The wife was in the middle of completing her Master’s degree at UNC
in chemistry. Both the husband and wife were adamantly vocal about their levels of stress
at their occupations. Near the completion of their training both the husband and wife
were in totally different occupations, which were much less stressful and may have
accounted for the decreases observed in depression. They both expressed how much
happier they were that those chapters in their lives had closed.
The lack of significant increases in measures of cognitive function do not agree
with multiple research investigations showing significant increases in measures of
cognitive function following a cognitive training protocol (Ball et al., 2007; Cherrier et
al., 2013; Ferguson et al., 2007b; Hassler et al., 2010; Kawashima, 2013; Kesler et al.,
2013; Mahncke et al., 2006; Smith et al., 2009; & Wolinsky et al., 2006) and aerobic
exercise at similar intensities as presented in this study (Barnes et al., 2003; Barnes et al.,
2013; Lautenschlager et al., 2008; Masley et al., 2009; Potter & Keeling, 2005; &
Zoeller, 2010). This, similar to the CAN-AER-COG group did not support the hypothesis
that this type of training would produce synergistic increases observed in measures of
cognitive function. Yet, like the CAN-AER-COG group the results suggest that there may
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be other factors responsible for the lack of substantial and significant increases. Perhaps,
the results of the combined training suggest a neurological conflict of sorts which, like
the equivalent CAN-AER-COG group, may have played a role in the lack of ability of the
brain to appropriate the amount of processing capabilities between two difficult tasks.
Cognitive and Flexibility Training
(CAN-COG)
The results of this study for the CAN-COG group do not fully corroborate with
other studies that have shown increases in aspects of cognitive function with multiple
interventions consisting of various populations (Ball et al., 2007; Cherrier et al., 2013;
Ferguson et al., 2007b; Hassler et al., 2010; Kawashima, 2013; Kesler et al., 2013;
Mahncke et al., 2006; Smith et al., 2009; & Wolinsky et al., 2006). It was hypothesized
that cognitive training would elicit increases in cognitive function, yet the CAN-COG
group showed no significant increases in any measure of cognitive function. A few
reasons to explain the lack of juxtaposition between the specifically designed training
software and the outcomes observed may be (A) the level of difficulty was consistently
high and may not be entirely appropriate for those who are undergoing treatment for
cancer, (B) the type of games may not have been engaging or stimulating enough to
encourage full cognitive involvement from the participants, or (C) the software itself fails
to accurately train cognitive processes that its designers suggested it would.
A factor that should be considered, but was excluded from this evaluation because
of low sample size and a wide variety of completed education levels, was how education
played a role as a covariate in these analyses. Although insignificant, LMI scaled, LMII
DR raw, COWAT gender, age, and education all increased (20%, 19%, 156%, 574%,
60%, respectively) from pre to post. TMT-B reaction time to completion also decreased

119
(-26%). These results may suggest that cognitive training, especially in this population
does have a place with regards to the reduction of CRCI; however, it would appear that
the training itself may have been far too difficult for those who were undergoing
treatment for cancer, and potentially the NC-CON group as well.
Psychosocial measures of Beck depression significantly (pre 8.2 ± 1.8 vs. post 3.4
± 1.5, p < 0.05) decreased (-59%) and QOL significantly (pre 22.1 ± 1.5 vs. post 23.5 ±
1.5, p < 0.05) increased (6%). All measures of Piper fatigue (index, behavioral, affective,
sensory, and cognitive) also decreased (-52%, -49%, -23%, -38%, -32%, respectively),
which may actually be attributable to the flexibility component of this intervention. The
results do not suggest that the cognitive training alone using NeuroActive® software was
responsible for the results observed for this group. Again, anecdotally, multiple
participants who were in this group reported that they felt like the tasks were far too
difficult to process while undergoing treatment. Participants also mentioned that they
often times felt overwhelmed and frustrated by the complexity of the tasks, which many
times resulted in a tearful participant.
Summary
Taken together, it appears that for the purpose of this study that aerobic training at
an often self-reported (RPE) moderate intensity was the most effective intervention to
increase measures of cognitive function, flexibility, VO2peak, and QOL, and reduce fatigue
and depression in cancer survivors.
Conclusion
To our knowledge, there have been no studies examining the effects of a
combined cognitive and aerobic training intervention on cognitive function in cancer
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survivors, specifically, a majority of those undergoing treatment. Although results of this
current study failed to show significant differences between each of the training groups in
cognitive, physiological, or psychosocial function, there are five important outcomes that
were observed.
First, it is imperative that cognitive and aerobic training at a moderate intensity
not be overlooked with regards to CRCI reduction methodologies. For the CAN-AERCOG group, there were no significant increases observed in measures of cognitive
function, yet there were observed pre-to-post increases observed among each of the
individual treatment groups, with the exception of controls. This may imply that
combined training of this nature may be too demanding for the individual to do well at
both cognitive and aerobic training, simultaneously.
Second, among individual treatment groups, 30 minutes of aerobic cycling at an
often self-reported (RPE) moderate intensity was observed to produce the overall greatest
number of pre-to-post increases in measures of cognitive, physiological, and psychosocial
function. For those who are working with cancer survivors in a rehabilitative setting,
these results should further reinforce the importance of this type of activity during
training. Specifically, those following intensity-based programming can readily follow
the aerobic training conducted in this study. Intensities that were mostly tolerable for
those undergoing treatment are adaptable in cases where side effects of treatment
overwhelmed the client (e.g., fatigue, depression, nausea, diarrhea). Upon occurrence, the
reduction of revolutions per minute or resistance applied to the flywheel of the ergometer,
may be appropriately substituted with RPE. In addition, for emerging rehabilitation
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programs, a cycle ergometer is a cost-effective, durable apparatus that should not be
excluded when developing a program.
Third, 30 minutes of flexibility training as detailed in this investigation should
also not be overlooked. During the development of this project, it was thought that
flexibility training would serve as an ethically appropriate control group that would not
force our lab to require cancer survivors to be subjected to the “wait list.” Results
obtained following this intervention that verbal measurements of cognitive function,
VO2peak, Sit and Reach, all Piper fatigue scores, Beck depression scores, and QOL all
improved were unexpected. Although the mechanisms are not currently known,
flexibility training as presented in this investigation should (A) be further investigated to
identify mechanisms of action, (B) be incorporated to a greater extent in cancer
rehabilitation, (C) to be considered as a more ethically appropriate control group for
studies conducted in cancer survivors as opposed to the “wait list” control group, and (D)
investigated further to see if similar results are obtained in other studies.
Fourth, cognitive training alone should be considered when developing cancer
rehabilitation programs that are aiming to address CRCI. Multiple studies presented in
this investigation have corroborated the efficacy of cognitive training interventions in
many different populations, but few have aimed to address CRCI in cancer survivors. It
appears that cognitive training using NeuroActive® software may be mild-to-moderately
beneficial, but may not be the most appropriate type of cognitive training software for
this population. Many anecdotal comments included frustration with the level of
difficulty of this program. In addition, the design of the BrainBike® itself with computer
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interfaces that are grossly elevated and force participants to be in a constant state of neck
extension may have compounded the level of frustration among this sample.
Finally, despite small sample sizes, replacement of missing data, treatment
adjustments by subject, and attrition issues this investigation still breaks ground on
multiple levels considering the novelty of designing an intervention that is addressing an
issue in cancer survivors that is just beginning to come to light from two respected and
substantiated intervention methods. This investigation was an attempt to evaluate how
these two methods may be best utilized to reduce CRCI, thereby increasing QOL in
cancer survivors. These results, although not revolutionary or conclusive, do provide
fertile ground for future studies.
Future Research
Research in this field is just surfacing in regards to the effectiveness of cognitive
training among the general apparently healthy population and even less in a cancer
survivor population. Translational research should be the next avenue of focus to evaluate
further how aerobic and cognitive training may best affect volumetric and functional
aspects of brain physiology for both animal and human models. Methods such as fMRI,
CT scan, and EEG technology should be employed to better elaborate upon possible
mechanisms behind changes in measures of cognitive function and the relationship to
volumetric alterations in brain tissue.
The least effective intervention was observed to be the CAN-AER-COG group;
however, the individual treatment groups produced a myriad of differing but positive
increases in cognitive, physiological, and psychosocial function. At this time, it would be
unwise to abandon cognitive and aerobic training altogether, but rather modify the levels
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of physical and cognitive difficulty. NeuroActive® software was designed to address
multiple aspects of cognitive function, but was anecdotally reported to be far too difficult
for both CAN and NC participants to do while cycling. It was evident during training that
those who were undergoing cancer treatment experienced the greatest amount of
difficulty. The next phase of this type of research should be to compare at-home types of
cognitive training programs against the results of this study. In addition, the creation of a
blocked schedule that would maintain three days a week of aerobic and flexibility
training, but incorporate cognitive training between each of the aerobic and flexibility
training sessions should be the next logical course of action.
Treatment-related differences in outcomes with cognitive and aerobic training
need to be further developed. Our group has also evaluated the effects of cognitive and
aerobic training on participants who underwent radiation treatment only. Research has
indicated that radiation treatment for cancer may result in cognitive and/or psychosocial
deficits similar to those undergoing chemotherapy (Attia, Page, Lesser, & Chan, 2014;
Kim et al., 2009; Noal et al., 2011). Therefore, by evaluating response differences
between both types of broad treatment groups this may better elucidate methods of
rehabilitation that are more focused on the individual needs of the participant.
Finally, dose-related treatment responses to cognitive and aerobic training need to
be evaluated. Multiple reports have suggested that with a greater dosage of chemotherapy
and/or radiation that aspects cognitive dysfunction become much more apparent Collins,
Mackenzie, Tasca, Scherling, & Smith, 2013; Lawrence et al., 2010).
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1

35

35 SMEAN(WMS_IV_LMIICP_RAW_PRE)

12 WMS_IV_LMIICP_RAW_POST_1

1

1

35

35 SMEAN(WMS_IV_LMIICP_RAW_POST)
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Creating Function
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First
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Creating Function

13 TMT_A_RAW_PRE_1

0

1

35

35 SMEAN(TMT_A_RAW_PRE)

14 TMT_A_RAW_POST_1

1

1

35

35 SMEAN(TMT_A_RAW_POST)

15 TMT_B_RAW_PRE_1

0

1

35

35 SMEAN(TMT_B_RAW_PRE)

16 TMT_B_RAW_POST_1

1

1

35

35 SMEAN(TMT_B_RAW_POST)

17 WAIS_IV_BD_RAW_PRE_1

0

1

35

35 SMEAN(WAIS_IV_BD_RAW_PRE)

18 WAIS_IV_BD_RAW_POST_1

0

1

35

35 SMEAN(WAIS_IV_BD_RAW_POST)

19 WAIS_IV_BD_SCALED_PRE_1

0

1

35

35 SMEAN(WAIS_IV_BD_SCALED_PRE)
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Replaced
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Values
First

N of
Valid
Cases

Creating Function

Last

20 WAIS_IV_BD_SCALED_POST_1

0

1

35

35 SMEAN(WAIS_IV_BD_SCALED_POST)

21 WAIS_IV_LNS_RAW_PRE_1

1

1

35

35 SMEAN(WAIS_IV_LNS_RAW_PRE)

22 WAIS_IV_LNS_RAW_POST_1

1

1

35

35 SMEAN(WAIS_IV_LNS_RAW_POST)

23 WAIS_IV_LNS_SCALED_PRE_1

1

1

35

35 SMEAN(WAIS_IV_LNS_SCALED_PRE)

24 WAIS_IV_LNS_SCALED_POST_1

1

1

35

35 SMEAN(WAIS_IV_LNS_SCALED_POST)

25 WAIS_IV_CD_RAW_PRE_1

0

1

35

35 SMEAN(WAIS_IV_CD_RAW_PRE)
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Result Variable

N of Replaced
Missing Values

Case Number of
Non-Missing
Values
First

N of
Valid
Cases

Creating Function

Last

26 WAIS_IV_CD_RAW_POST_1

0

1

35

35 SMEAN(WAIS_IV_CD_RAW_POST)

27 WAIS_IV_CD_SCALED_PRE_1

0

1

35

35 SMEAN(WAIS_IV_CD_SCALED_PRE)

28 WAIS_IV_CD_SCALED_POST_1

0

1

35

35 SMEAN(WAIS_IV_CD_SCALED_POST)

29 COWAT_Z_G_PRE_1

0

1

35

35 SMEAN(COWAT_Z_G_PRE)

30 COWAT_Z_G_POST_1

0

1

35

35 SMEAN(COWAT_Z_G_POST)

31 COWAT_Z_A_PRE_1

0

1

35

35 SMEAN(COWAT_Z_A_PRE)

32 COWAT_Z_A_POST_1

0

1

35

35 SMEAN(COWAT_Z_A_POST)
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Result Variable

N of Replaced
Missing Values

Case Number of NonMissing Values
First

N of Valid
Cases

Creating Function

Last

33 COWAT_Z_ED_PRE_1

1

1

35

35 SMEAN(COWAT_Z_ED_PRE)

34 COWAT_Z_ED_POST_1

0

1

35

35 SMEAN(COWAT_Z_ED_POST)

35 SBP_PRE_1

0

1

35

35 SMEAN(SBP_PRE)

36 SBP_POST_1

3

1

35

35 SMEAN(SBP_POST)

37 DBP_PRE_1

0

1

35

35 SMEAN(DBP_PRE)

38 DBP_POST_1

3

1

35

35 SMEAN(DBP_POST)

39 RHR_PRE_1

0

1

35

35 SMEAN(RHR_PRE)

40 RHR_POST_1

3

1

35

35 SMEAN(RHR_POST)

41 HEIGHT_IN_1

0

1

35

35 SMEAN(HEIGHT_IN)

42 WEIGHT_LBS_1

0

1

35

35 SMEAN(WEIGHT_LBS)
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Creating Function

Last

43 FVC_L_PRE_1

0

1

35

35 SMEAN(FVC_L_PRE)

44 FVC_L_POST_1

3

1

35

35 SMEAN(FVC_L_POST)

45 FVC_PRED_PRE_1

3

1

35

35 SMEAN(FVC_PRED_PRE)

46 FVC_PRED_POST_1

6

1

35

35 SMEAN(FVC_PRED_POST)

47 FEV1_PRE_1

1

1

35

35 SMEAN(FEV1_PRE)

48 FEV1_POST_1

4

1

35

35 SMEAN(FEV1_POST)

49 FEV1_PRED_PRE_1

3

1

35

35 SMEAN(FEV1_PRED_PRE)

50 FEV1_PRED_POST_1

6

1

35

35 SMEAN(FEV1_PRED_POST)

51 VO2PEAK_PRE_1

0

1

35

35 SMEAN(VO2PEAK_PRE)
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Result Variable

N of Replaced
Missing Values

Case Number of Non-Missing
Values
First

N of Valid
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Creating Function

Last

52

VO2PEAK_POST_1

2

1

35

35 SMEAN(VO2PEAK_POST)

53

LAT_PD_PRE_1

3

1

35

35 SMEAN(LAT_PD_PRE)

54

LAT_PD_POST_1

3

1

35

35 SMEAN(LAT_PD_POST)

55

SPRESS_PRE_1

6

1

35

35 SMEAN(SPRESS_PRE)

56

SPRESS_POST_1

5

1

35

35 SMEAN(SPRESS_POST)

57

CPRESS_PRE_1

3

1

35

35 SMEAN(CPRESS_PRE)

58

CPRESS_POST_1

4

1

35

35 SMEAN(CPRESS_POST)

59

SROW_PRE_1

3

1

35

35 SMEAN(SROW_PRE)
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Result Variable

N of Replaced Missing
Values

Case Number of Non-Missing
Values
First

N of Valid
Cases

Creating Function

Last

60 SROW_POST_1

3

1

35

35 SMEAN(SROW_POST)

61 LCURL_PRE_1

0

1

35

35 SMEAN(LCURL_PRE)

62 LCURL_POST_1

3

1

35

35 SMEAN(LCURL_POST)

63 LEXT_PRE_1

2

1

35

35 SMEAN(LEXT_PRE)

64 LEXT_POST_1

3

1

35

35 SMEAN(LEXT_POST)

65 LPRESS_PRE_1

1

1

35

35 SMEAN(LPRESS_PRE)

66 LPRESS_POST_1

3

1

35

35 SMEAN(LPRESS_POST)

67 STWRU_PRE_1

0

1

35

35 SMEAN(STWRU_PRE)
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N of Replaced
Missing Values

Case Number of Non-Missing
Values
First

N of Valid Cases

Creating Function

Last

68

STWRU_POST_1

2

1

35

35 SMEAN(STWRU_POST)

69

STWRL_PRE_1

1

1

35

35 SMEAN(STWRL_PRE)

70

STWRL_POST_1

2

1

35

35 SMEAN(STWRL_POST)

71

PLANK_PRE_1

6

1

35

35 SMEAN(PLANK_PRE)

72

PLANK_POST_1

4

1

35

35 SMEAN(PLANK_POST)

73

HGR_PRE_1

1

1

35

35 SMEAN(HGR_PRE)

74

HGR_POST_1

2

1

35

35 SMEAN(HGR_POST)

75

HGL_PRE_1

1

1

35

35 SMEAN(HGL_PRE)

76

HGL_POST_1

2

1

35

35 SMEAN(HGL_POST)
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Result Variable

N of Replaced
Missing Values

Case Number of Non-Missing
Values
First

N of Valid Cases

Creating Function

Last

77

SANDR_PRE_1

1

1

35

35 SMEAN(SANDR_PRE)

78

SANDR_POST_1

3

1

35

35 SMEAN(SANDR_POST)

79

PIPER_I_PRE_1

0

1

35

35 SMEAN(PIPER_I_PRE)

80

PIPER_I_POST_1

1

1

35

35 SMEAN(PIPER_I_POST)

81

PIPER_B_PRE_1

0

1

35

35 SMEAN(PIPER_B_PRE)

82

PIPER_B_POST_1

1

1

35

35 SMEAN(PIPER_B_POST)

83

PIPER_A_PRE_1

0

1

35

35 SMEAN(PIPER_A_PRE)

84

PIPER_A_POST_1

2

1

35

35 SMEAN(PIPER_A_POST)
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N of Replaced
Missing Values

Case Number of Non-Missing
Values
First

N of Valid Cases

Creating Function

Last

85

PIPER_S_PRE_1

0

1

35

35 SMEAN(PIPER_S_PRE)

86

PIPER_S_POST_1

2

1

35

35 SMEAN(PIPER_S_POST)

87

PIPER_C_PRE_1

0

1

35

35 SMEAN(PIPER_C_PRE)

88

PIPER_C_POST_1

2

1

35

35 SMEAN(PIPER_C_POST)

89

BECK_PRE_1

1

1

35

35 SMEAN(BECK_PRE)

90

BECK_POST_1

2

1

35

35 SMEAN(BECK_POST)

91

QOL_PRE_1

0

1

35

35 SMEAN(QOL_PRE)

92

QOL_POST_1

4

1

35

35 SMEAN(QOL_POST)
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